| For: | Sarantis P, Koustas E, Papadimitropoulou A, Papavassiliou AG, Karamouzis MV. Pancreatic ductal adenocarcinoma: Treatment hurdles, tumor microenvironment and immunotherapy. World J Gastrointest Oncol 2020; 12(2): 173-181 [PMID: 32104548 DOI: 10.4251/wjgo.v12.i2.173] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v12/i2/173.htm |
| Number | Citing Articles |
| 1 |
Ariba Anwar, Viswa Raj Lal, Harsimran Kaur Hora, Priyangulta Beck, Mukesh Nitin. Computational & System Biology Approaches in Identifying Potential Natural Plant Based Compounds in Combating Pancreatic Cancer. Research Journal of Life Sciences, Bioinformatics, Pharmaceutical and Chemical Sciences 2025; 11(1) doi: 10.26479/2025.1101.02
|
| 2 |
Olamide T. Olaoba, Funmilayo C. Ligali, Zaccheaus O. Alabi, Amos O. Akinyemi, Kehinde S. Ayinde. Of immune checkpoint maladies and remedies: The throwing of jabs in the oncogenic ring of PDAC. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2021; 1875(1) doi: 10.1016/j.bbcan.2020.188483
|
| 3 |
Gehan Botrus, Denise Roe, Gayle S. Jameson, Pedro Luiz Serrano Uson Junior, Ronald Lee Korn, Lana Caldwell, Taylor Bargenquast, Max Miller, Erkut Hasan Borazanci. Mitomycin C in Homologous Recombination Deficient Metastatic Pancreatic Cancer after Disease Progression on Platinum-Based Chemotherapy and Olaparib. Biomedicines 2022; 10(11) doi: 10.3390/biomedicines10112705
|
| 4 |
Jihoon Ko, Jiyoung Song, Nakwon Choi, Hong Nam Kim. Patient‐Derived Microphysiological Systems for Precision Medicine. Advanced Healthcare Materials 2024; 13(7) doi: 10.1002/adhm.202303161
|
| 5 |
Tatekalva Sandhya, Seema Kumari, Adem Meghapriya, V.K. Chaithanya Manam, Ganji Purnachandra Nagaraju, Mundla Srilatha. Mapping cellular heterogeneity and dynamic interactions in pancreatic cancer. Journal of Controlled Release 2026; 393 doi: 10.1016/j.jconrel.2026.114757
|
| 6 |
Abdulaziz Elemosho, Odysseas P. Chatzipanagiotou, Meher Angez, Andrea Baldo, Areesh Mevawalla, Qaidar Alizai, Timothy M. Pawlik. Early postoperative carbohydrate antigen 19-9 normalization drives prognosis after pancreatic ductal adenocarcinoma resection. Journal of Gastrointestinal Surgery 2026; 30(8) doi: 10.1016/j.gassur.2026.102459
|
| 7 |
Zayan Alidina, Agha Ahmed Muhammad Hussain, Illiyun Banani, Muhammad Mohsin Khan, Timothy M. Pawlik. Radiomics for early detection of pancreatic cancer: a systematic review and meta-analysis. Journal of Gastrointestinal Surgery 2026; 30(5) doi: 10.1016/j.gassur.2026.102374
|
| 8 |
David L. Saltman, Tyler J. Nielsen, Davide Salina, David R. Hout, Frank B. McMahon, Boris R. Valev, Michael Huk, Pranil K. Chandra, Jeremy Spille, Robert S. Seitz, Brock L. Schweitzer. Characterization of the tumor immune-microenvironment of adenocarcinoma of lung with a metastatic lesion in the pancreas treated successfully with first-line, single-agent pembrolizumab. Therapeutic Advances in Medical Oncology 2021; 13 doi: 10.1177/17588359211010156
|
| 9 |
Zelin Hou, Fengchun Lu, Jiajing Lin, Yuwei Wu, Linjin Chen, Haizong Fang, Linlin Chen, Shihan Zhang, Heguang Huang, Yu Pan. Loss of Annexin A1 in macrophages restrains efferocytosis and remodels immune microenvironment in pancreatic cancer by activating the cGAS/STING pathway. Journal for ImmunoTherapy of Cancer 2024; 12(9) doi: 10.1136/jitc-2024-009318
|
| 10 |
Wenjie Liu, Yuting Fang, Chao Zhang, Midan Xiang, Lijuan Qi, Aijiang Su, Yongkun Sun. Cost-effectiveness of NALIRIFOX versus Nab-paclitaxel and gemcitabine in previously untreated metastatic pancreatic ductal adenocarcinoma. BMC Gastroenterology 2025; 25(1) doi: 10.1186/s12876-025-03867-2
|
| 11 |
Francesco Balestra, Giorgia Panzetta, Maria De Luca, Federica Rizzi, Anna Ancona, Ilaria Grassi, Roberto Comparelli, Maria Lucia Curri, Gianluigi Giannelli, Nicoletta Depalo, Maria Principia Scavo. Pancreatic Cancer-Derived Small Extracellular Vesicles Remodel Hepatic Pre-Metastatic Niche via Hybrid Epithelial–Mesenchymal States. International Journal of Molecular Sciences 2026; 27(12) doi: 10.3390/ijms27125270
|
| 12 |
Daniela Carbone, Cristiano Biancucci, Michele De Franco, Camilla Pecoraro, Silvia Gulino, Veronica Salmaso, Chiara Cavastracci Strascia, Stefano Moro, Patrizia Diana, Valentina Gandin, Barbara Parrino. 3-amino-1,2,4-triazine scaffolds as next-generation PDK inhibitors: Design, mechanistic insights, and efficacy in pancreatic ductal adenocarcinoma. European Journal of Medicinal Chemistry 2026; 318 doi: 10.1016/j.ejmech.2026.119202
|
| 13 |
Lasse Vedel Jørgensen, Emil Birch Christensen, Mike Bogetofte Barnkob, Torben Barington. The clinical landscape of CAR NK cells. Experimental Hematology & Oncology 2025; 14(1) doi: 10.1186/s40164-025-00633-8
|
| 14 |
Pipit Burasakarn, Kwanchanok Yochum, Sermsak Hongjinda, Anuparp Thienhiran, Pusit Fuengfoo. Analysis of risk factors associated with distant metastasis detected at laparotomy in patients with radiologically resectable pancreatic ductal adenocarcinoma. Surgical Practice 2024; 28(2) doi: 10.1111/1744-1633.12669
|
| 15 |
Aleksandra Ciechońska, Mateusz Wierzbicki, Barbara Nasiłowska, Barbara Wójcik, Wojciech Skrzeczanowski, Katarzyna Ziółkowska, Marta Kutwin. Aerosol-Derived Graphene Oxide Nanofilm Suppresses Adhesion-Dependent Survival and Migration in Pancreatic Ductal Adenocarcinoma Cells. International Journal of Molecular Sciences 2026; 27(10) doi: 10.3390/ijms27104341
|
| 16 |
Yi Jin, Ran Hu, Yufan Gu, Ailin Wei, Ang Li, Yong Zhang. Quantitative site-specific N-glycosylation analysis reveals IgG glyco-signatures for pancreatic cancer diagnosis. Clinical Proteomics 2024; 21(1) doi: 10.1186/s12014-024-09522-4
|
| 17 |
Jessica Schlatter, Wei Wei, YingYing Chen, Annick Melse, Yong Wang, Sara Guerra, Jose Oberholzer. Targeting IL-12 for pancreatic cancer immunotherapy: advances in delivery strategies and clinical translation. Frontiers in Immunology 2026; 17 doi: 10.3389/fimmu.2026.1755796
|
| 18 |
Sakshi Bansal, Vinit Sharma, Rajesh Gupta, Harjeet Singh, Naresh Sachdeva, Alka Bhatia, Anjali Aggarwal. Elevated neutrophil extracellular traps as potential diagnostic biomarkers in pancreatic ductal adenocarcinoma. Cellular Immunology 2026; 427 doi: 10.1016/j.cellimm.2026.105131
|
| 19 |
Shantel Angstadt, Qingfeng Zhu, Elizabeth M. Jaffee, Douglas N. Robinson, Robert A. Anders. Pancreatic Ductal Adenocarcinoma Cortical Mechanics and Clinical Implications. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.809179
|
| 20 |
Jason Y. Tang, Valentina L. Kouznetsova, Santosh Kesari, Igor F. Tsigelny. Development of a Diagnostic Model for Pancreatic Ductal Adenocarcinoma Using Machine Learning and Blood-Based miRNAs. Oncology 2024; doi: 10.1159/000540329
|
| 21 |
Belén Toledo, Aitor González-Titos, Pablo Hernández-Camarero, Elena López-Ruiz, Carmen Griñán-Lisón, Elisa Giovannetti, Juan Antonio Marchal, Macarena Perán. Impact of pancreatic proenzymes on pancreatic ductal adenocarcinoma associated fibroblasts. Scientific Reports 2025; 15(1) doi: 10.1038/s41598-025-24863-2
|
| 22 |
Lei Jiang. Establishment and analysis of a prognostic model of pancreatic ductal adenocarcinomas based on nerve-cancer crosstalk-related genes. International Journal of Clinical and Experimental Pathology 2024; 17(11) doi: 10.62347/GHUM8504
|
| 23 |
Landon L. Moore, Courtney W. Houchen. Evolving insights into pancreatic tumor initiation and progression through DCLK1-expressing tuft cells. Developmental Cell 2025; 60(6) doi: 10.1016/j.devcel.2025.02.014
|
| 24 |
Yijie Ma, Yiwen Yang, Huizhi Zhang, Joseph Mugaanyi, Yangke Hu, Shengdong Wu, Caide Lu, Shuqi Mao, Ke Wang. Sarcomatoid carcinoma of the pancreas (Review). Oncology Letters 2024; 28(4) doi: 10.3892/ol.2024.14610
|
| 25 |
Przemysław Kostro, Blanka Wolszczak-Biedrzycka, Edyta Kostro, Joanna Matowicka-Karna, Zbigniew Kamocki, Cezary Pawlukianiec, Mateusz Maciejczyk, Anna Zalewska, Justyna Dorf. Preoperative immunonutrition as a strategy for reducing oxidative stress and inflammation in pancreatic ductal adenocarcinoma. Frontiers in Immunology 2026; 17 doi: 10.3389/fimmu.2026.1889074
|
| 26 |
Daniel G. Chen, Jingyi Xie, Jongchan Choi, Rachel H. Ng, Rongyu Zhang, Sarah Li, Rick Edmark, Hong Zheng, Ben Solomon, Katie M. Campbell, Egmidio Medina, Antoni Ribas, Purvesh Khatri, Lewis L. Lanier, Philip J. Mease, Jason D. Goldman, Yapeng Su, James R. Heath. Integrative systems biology reveals NKG2A-biased immune responses correlate with protection in infectious disease, autoimmune disease, and cancer. Cell Reports 2024; 43(3) doi: 10.1016/j.celrep.2024.113872
|
| 27 |
Epiphane K. Silli, Zhenjiang Zheng, Xintao Zhou, Mengfei Li, Jiali Tang, Ruizhe Guo, Chunlu Tan, Ying Wang. Design optimization of Fucoidan-coating Cationic Liposomes for enhance Gemcitabine delivery. Investigational New Drugs 2024; 42(5) doi: 10.1007/s10637-024-01455-x
|
| 28 |
Varintra E. Lander, Jad I. Belle, Natalie L. Kingston, John M. Herndon, Graham D. Hogg, Xiuting Liu, Liang-I Kang, Brett L. Knolhoff, Savannah J. Bogner, John M. Baer, Chong Zuo, Nicholas C. Borcherding, Daniel P. Lander, Cedric Mpoy, Jalen Scott, Michael Zahner, Buck E. Rogers, Julie K. Schwarz, Hyun Kim, David G. DeNardo. Stromal Reprogramming by FAK Inhibition Overcomes Radiation Resistance to Allow for Immune Priming and Response to Checkpoint Blockade. Cancer Discovery 2022; 12(12) doi: 10.1158/2159-8290.CD-22-0192
|
| 29 |
Gyuntae Bae, Georgy Berezhnoy, Alejandra Flores, Claire Cannet, Hartmut Schäfer, Marc H. Dahlke, Patrick Michl, Markus W. Löffler, Alfred Königsrainer, Christoph Trautwein. Quantitative Metabolomics and Lipoprotein Analysis of PDAC Patients Suggests Serum Marker Categories for Pancreatic Function, Pancreatectomy, Cancer Metabolism, and Systemic Disturbances. Journal of Proteome Research 2024; 23(4) doi: 10.1021/acs.jproteome.3c00611
|
| 30 |
Yanzhen Yang, Qu Xie, Chuankai Shang, Lai Jiang, Guojun Ding, Dan Long, Cong Luo. The prognostic impact of surufatinib for the treatment of advanced pancreatic ductal adenocarcinoma: a single center real-world retrospective study. Frontiers in Oncology 2025; 15 doi: 10.3389/fonc.2025.1574934
|
| 31 |
Geou-Yarh Liou, Crystal J. Byrd. Diagnostic Bioliquid Markers for Pancreatic Cancer: What We Have vs. What We Need. Cancers 2023; 15(9) doi: 10.3390/cancers15092446
|
| 32 |
Kateřina Novotná, Lukáš Tenora, Barbara S. Slusher, Rana Rais. The Discovery of New Medicines in Academia. Advances in Pharmacology 2024; 100 doi: 10.1016/bs.apha.2024.04.003
|
| 33 |
Adi Jabarin, Guy Shtar, Valeria Feinshtein, Eyal Mazuz, Bracha Shapira, Shimon Ben-Shabat, Lior Rokach. Eravacycline, an antibacterial drug, repurposed for pancreatic cancer therapy: insights from a molecular-based deep learning model. Briefings in Bioinformatics 2024; 25(3) doi: 10.1093/bib/bbae108
|
| 34 |
Benoit Immordino, Mafalda Angelica Rocco, Annalisa Comandatore, Gaby van der Zee, Mahrou Vahabi, Luca Morelli, Elisa Giovannetti. The emerging role of AXL in pancreatic cancer: Biomarker potential and therapeutic targeting to counteract drug resistance. Drug Resistance Updates 2026; 87 doi: 10.1016/j.drup.2026.101408
|
| 35 |
. 2024; doi: 10.70675/3c9a1953zce0cz4a3ez9a7bz7328f996231c
|
| 36 |
Yesiboli Tasiheng, Jiayideng Kenjiabieke, Nuerzhati Tasiheng, Kawushaer Adilijiang, He Cheng. TCF7L2/DEPDC1 axis contributes to tumor progression by promoting cell proliferation, aerobic glycolysis, and immunosuppression in pancreatic cancer. Clinical and Experimental Medicine 2026; 26(1) doi: 10.1007/s10238-026-02109-3
|
| 37 |
Allison A Fitzgerald, Shangzi Wang, Veena Agarwal, Emily F Marcisak, Annie Zuo, Sandra A Jablonski, Melanie Loth, Elana J Fertig, John MacDougall, Eugene Zhukovsky, Shubhendu Trivedi, Dimple Bhatia, Vince O'Neill, Louis M Weiner. DPP inhibition alters the CXCR3 axis and enhances NK and CD8+ T cell infiltration to improve anti-PD1 efficacy in murine models of pancreatic ductal adenocarcinoma. Journal for ImmunoTherapy of Cancer 2021; 9(11) doi: 10.1136/jitc-2021-002837
|
| 38 |
Ruimeng Yang, Catherine Gereg, Maria C. Olave, Esther Yoon, Guoping Cai. Diagnostic utility of p53, SMAD4, and the novel biomarker PON2 in FNA of pancreatic ductal adenocarcinoma. Cancer Cytopathology 2025; 133(11) doi: 10.1002/cncy.70058
|
| 39 |
V. S. Tikhonova, I. S. Gruzdev, E. V. Kondratyev, K. A. Mikhaylyuk, G. G. Kаrmаzаnovsky. Texture analysis of contrast enhancement СT in the differential diagnosis of mass-forming pancreatitis and pancreatic ductal adenocarcinoma. Medical Visualization 2022; doi: 10.24835/1607-0763-1068
|
| 40 |
Yanzhen Yang, Chuankai Shang, Lei Chen, Dan Long, Li Fang, Cong Luo. Evaluating cadonilimab efficacy and safety in retrospective first line treatment for advanced pancreatic cancer. iScience 2025; 28(9) doi: 10.1016/j.isci.2025.113136
|
| 41 |
Yi-Ping Huang, Te-Chun Hsia, Chun-An Yeh, Yi-Shih Ma, Sheng-Yao Hsu, Yi-Chung Liu, Ping-Chiang Lyu, Kuang-Chi Lai, Shu-Fen Peng, Jin-Cherng Lien, Wen-Tsong Hsieh, Helena Moreira. PW06 Triggered Fas-FADD to Induce Apoptotic Cell Death In Human Pancreatic Carcinoma MIA PaCa-2 Cells through the Activation of the Caspase-Mediated Pathway. Oxidative Medicine and Cellular Longevity 2023; 2023 doi: 10.1155/2023/3479688
|
| 42 |
Mayank Baranwal, Santhoshi Krishnan, Morgan Oneka, Timothy Frankel, Arvind Rao. CGAT: Cell Graph ATtention Network for Grading of Pancreatic Disease Histology Images. Frontiers in Immunology 2021; 12 doi: 10.3389/fimmu.2021.727610
|
| 43 |
Abdullah Khalid, Ali Anjum Fazal, Manav Shah, Danielle DePeralta, Sepideh Gholami, Elliot Newman, Marcovalerio Melis, Matthew J. Weiss. Survival Disparities in Early‐Onset Pancreatic Cancer (EOPC): The Role of Socioeconomic Status and Healthcare Access. Journal of Surgical Oncology 2026; 133(3) doi: 10.1002/jso.70148
|
| 44 |
Graziana Digiacomo, Francesco Volta, Ingrid Garajova, Rita Balsano, Andrea Cavazzoni. Biological Hallmarks and New Therapeutic Approaches for the Treatment of PDAC. Life 2021; 11(8) doi: 10.3390/life11080843
|
| 45 |
Kritisha Bhandari, Wei-Qun Ding. Protein Arginine Methyltransferases in Pancreatic Ductal Adenocarcinoma: New Molecular Targets for Therapy. International Journal of Molecular Sciences 2024; 25(7) doi: 10.3390/ijms25073958
|
| 46 |
Pablo Braceras Arias, Silvia Burgos Postigo, Lidia B. Alejo. Impact of Hypertrophy‐Oriented Resistance Training on Muscle Mass and Quality of Life in Patients with Unresectable Pancreatic Cancer (HY‐PANC): Study Protocol for a Randomized Controlled Trial. Current Protocols 2026; 6(7) doi: 10.1002/cpz1.70410
|
| 47 |
Omar F. Luna, Yomkippur V. Perez, Daniele P. Ferrari, Sana S. Sayedipour, Miriam Royo, Gerardo A. Acosta, Luis J. Cruz, Frauke Alves, Erik Agner, Magne O. Sydnes, Fernando Albericio. Impact of N-Terminal PEGylation on Synthesis and Purification of Peptide-Based Cancer Epitopes for Pancreatic Ductal Adenocarcinoma (PDAC). ACS Omega 2024; 9(32) doi: 10.1021/acsomega.4c02604
|
| 48 |
Vanessa I. Rodriguez, Jamila Mammadova, Jennifer B. Permuth, Anjuli Luthra, Luis Pena, Mark Friedman, Aamir Dam, Saraswathi Cappelle, Mokenge P. Malafa, Candice Hallmon, Cassandra Miranda, Shaffer R.S. Mok. Elevated Urinary Levels of Fungal and Environmental Toxins in Patients with Pancreatic Ductal Adenocarcinoma. Journal of Gastrointestinal Cancer 2025; 56(1) doi: 10.1007/s12029-024-01125-4
|
| 49 |
Rana Alfardan. Effect of Small Nucleolar RNA H/ACA Box 64 (SNORA64) on Apoptosis Regulator Genes in Pancreatic Cancer in Vitro. F1000Research 2026; 15 doi: 10.12688/f1000research.173746.3
|
| 50 |
Pankti C. Balar, Vasso Apostolopoulos, Vivek P. Chavda. A new era of immune therapeutics for pancreatic cancer: Monoclonal antibodies paving the way. European Journal of Pharmacology 2024; 969 doi: 10.1016/j.ejphar.2024.176451
|
| 51 |
Kyung Seo Joo, Sun Jin Sym, Kwang-Min Kim, Dongwoo Khang. Strategies for Pancreatic Cancer-Responsive Nanodrug Platforms Targeting Tumor Hypoxic Environments. International Journal of Nanomedicine 2025; doi: 10.2147/IJN.S548825
|
| 52 |
Rana Alfardan. Effect of Small Nuclear RNA 64 (SNORA64) on Apoptosis Regulator Genes in Pancreatic Cancer in Vitro. F1000Research 2026; 15 doi: 10.12688/f1000research.173746.1
|
| 53 |
Jayita Roy, Aniket Kumar, Shouvik Chakravarty, Nidhan K Biswas, Srikanta Goswami, Anup Mazumder. Dynamic interaction of MYC enhancer RNA with YEATS2 protein regulates MYC gene transcription in pancreatic cancer. EMBO Reports 2025; 26(10) doi: 10.1038/s44319-025-00446-0
|
| 54 |
Cristina Mosconi, Maria Adriana Cocozza, Filippo Piacentino, Federico Fontana, Alberta Cappelli, Francesco Modestino, Andrea Coppola, Diego Palumbo, Paolo Marra, Paola Maffi, Lorenzo Piemonti, Antonio Secchi, Claudio Ricci, Riccardo Casadei, Gianpaolo Balzano, Massimo Falconi, Giulio Carcano, Antonio Basile, Anna Maria Ierardi, Gianpaolo Carrafiello, Francesco De Cobelli, Rita Golfieri, Massimo Venturini. Interventional Radiological Management and Prevention of Complications after Pancreatic Surgery: Drainage, Embolization and Islet Auto-Transplantation. Journal of Clinical Medicine 2022; 11(20) doi: 10.3390/jcm11206005
|
| 55 |
Chyntia Sherlyn Bunardi, Minseo Yeom, Prisca Kosasih, Han Han, Wenqi Wang, Gayoung Seo. MAP4K signaling pathways in cancer: roles, mechanisms and therapeutic opportunities. Experimental & Molecular Medicine 2025; 57(10) doi: 10.1038/s12276-025-01544-8
|
| 56 |
Adib Miraki Feriz, Arezou Khosrojerdi, Nafiseh Erfanian, Setareh Azarkar, Seyed Mehdi Sajjadi, Mohammad Javad Shojaei, Mohammad Javad Vaferi, Hossein Safarpour, Vito Racanelli. Targeting the dynamic transcriptional landscape of Treg subpopulations in pancreatic ductal adenocarcinoma: Insights from single-cell RNA sequencing analysis with a focus on CTLA4 and TIGIT. Immunobiology 2024; 229(4) doi: 10.1016/j.imbio.2024.152822
|
| 57 |
Daniela Carbone, Francesca Terrana, Ludovica Sciuto, Camilla Pecoraro, Geng Xu, Stella Cascioferro, Girolamo Cirrincione, Godefridus J. Peters, Elisa Giovannetti, Barbara Parrino, Patrizia Diana. Novel Pyrazolo [1,5‐a]−1,3,5‐Triazine Derivatives as CDK7 Inhibitors: Synthesis and Biological Insights in Pancreatic Ductal Adenocarcinoma Models. ChemMedChem 2025; 20(19) doi: 10.1002/cmdc.202500448
|
| 58 |
Rita Ghosh, Pinpin Sui, Danielle Fritze, Sarahi Fernandez, Audrie Torres, Jillian Woodworth, Francisco G. Cigarroa, Glenn A. Halff, Addanki P. Kumar. Characterization of metabolomic associated with pancreatic cancer patients with overweight and obesity. Clinical Nutrition 2025; 51 doi: 10.1016/j.clnu.2025.06.015
|
| 59 |
Vivek Shit, Mahesh Kumar Dhakar, Manoj Kumar. Computational Repurposing of Natural Compounds from Drimia indica, an Underutilized Medicinal Plant, for Targeting Src‐Mediated Pancreatic Cancer Pathways. ChemistrySelect 2025; 10(25) doi: 10.1002/slct.202405905
|
| 60 |
Benedetta Ferrara, Erica Dugnani, Antonio Citro, Marco Schiavo Lena, Paolo Marra, Paolo Riccardo Camisa, Martina Policardi, Tamara Canu, Antonio Esposito, Claudio Doglioni, Lorenzo Piemonti. ASO Author Reflections: Bridging the Gap in PDAC Research: The Intraportal Model as a Platform for Studying Preclinical Liver Metastasis. Annals of Surgical Oncology 2024; 31(10) doi: 10.1245/s10434-024-15655-5
|
| 61 |
Dilara Aylar, Ayse Karatug Kacar. Studies on Treatment Within the Scope of Medical Biotechnology for Pancreatic Diseases. Molecular Biotechnology 2025; 67(4) doi: 10.1007/s12033-024-01142-5
|
| 62 |
Yuanyuan Xu, Caiping He, Wenyan Jie, Qingqing Zhou, Chunhua Yang, Junmin Quan, Wei Xiong, Haiqiang Wu. Dual-targeted iRGD-functionalized, DPP4-responsive micelles carrying an isoQC inhibitor remodel the tumor microenvironment in pancreatic cancer. Materials & Design 2026; 268 doi: 10.1016/j.matdes.2026.116564
|
| 63 |
Jingyi Zhou, Kangnan Zhang, Chuan Liu, Jiang Long, Haitao Gu, Hanguang Dong, Chuntao Wu, Ling Xu, Fan Wang, Qi Li. Utidelone suppresses PDAC growth and enhances gemcitabine therapy by inducing immunogenic cell death. iScience 2025; 28(6) doi: 10.1016/j.isci.2025.112509
|
| 64 |
Dennis Slobodzian, Amir Kordijazi. Deep Learning Framework for Early Detection of Pancreatic Cancer Using Multi-modal Medical Imaging Analysis. Journal of Imaging Informatics in Medicine 2026; doi: 10.1007/s10278-026-01998-w
|
| 65 |
Mustafa B. A. Djamgoz, Valerie Jentzsch. Integrative Management of Pancreatic Cancer (PDAC): Emerging Complementary Agents and Modalities. Nutrition and Cancer 2022; 74(4) doi: 10.1080/01635581.2021.1934043
|
| 66 |
Alessandro Gregori, Cecilia Bergonzini, Mjriam Capula, Giulia Mantini, Fatemeh Khojasteh-Leylakoohi, Annalisa Comandatore, Ghazaleh Khalili-Tanha, Alireza Khooei, Luca Morelli, Amir Avan, Erik H. Danen, Thomas Schmidt, Elisa Giovannetti. Prognostic Significance of Integrin Subunit Alpha 2 (ITGA2) and Role of Mechanical Cues in Resistance to Gemcitabine in Pancreatic Ductal Adenocarcinoma (PDAC). Cancers 2023; 15(3) doi: 10.3390/cancers15030628
|
| 67 |
Antonella Farina, Sara Tartaglione, Adele Preziosi, Patrizia Mancini, Antonio Angeloni, Emanuela Anastasi. PANC-1 Cell Line as an Experimental Model for Characterizing PIVKA-II Production, Distribution, and Molecular Mechanisms Leading to Protein Release in PDAC. International Journal of Molecular Sciences 2024; 25(6) doi: 10.3390/ijms25063498
|
| 68 |
Sophia Tsokkou, Ioannis Konstantinidis, Maria-Nefeli Georgaki, Dimitrios Kavvadas, Kyriaki Papadopoulou, Antonios Keramas, Antonia Sioga, Theodora Papamitsou, Sofia Karachrysafi. Gestational Diabetes Mellitus and Its Correlation in the Development of Pancreatic Cancer: A 10-Year Systematic Review. Cancers 2024; 16(10) doi: 10.3390/cancers16101840
|
| 69 |
Sirio Fiorino, Wandong Hong, Dario de Biase, Laura Mastrangelo, Francesca Maccioni, Alfonso Grottesi, Francesca Ambrosi, Luca Pincigher, Federico Lari, Christian Bergamini, Elio Jovine, Maddalena Zippi. Focus on the Interactive Cooperation Among Mechanotransduction and Biochemical Processes in Pancreatic Ductal Adenocarcinoma Development and Possible Adjuvant Role of Retinoic Acid for Its Treatment: A Narrative Review. Cancers 2026; 18(12) doi: 10.3390/cancers18121932
|
| 70 |
Tevhide Bilgen Özcan, Esra Pasaoglu, Osman Bilgin Gülçiçek, Palanisamy Nallasamy. Tumor Budding and E‐Cadherin Loss as Robust Prognostic Markers in Pancreatic Ductal Adenocarcinoma: A Study in a Turkish Patient Cohort. Canadian Journal of Gastroenterology and Hepatology 2025; 2025(1) doi: 10.1155/cjgh/9097621
|
| 71 |
Tingting Xu, Xiaoxuan Xu, Lijiao Yang, Xiaoyuan Chen, Shenghong Ju. Noninvasive Visualization of Obesity-Boosted Inflammation in Orthotopic Pancreatic Ductal Adenocarcinoma Using an Octapod Iron Oxide Nanoparticle. ACS Applied Bio Materials 2020; 3(9) doi: 10.1021/acsabm.0c00841
|
| 72 |
K.P. Ray, W. Cruces, Y. Mzannar, A. Aboukameel, S. Motorwala, T. Hadid, M.N. Al-Hallak, G.A. Ramirez, T.T. Tesfatsion, M.L. Docampo-Palacios, A.C. Collins, P.G. Jagtap, A.S. Azmi, H.Y. Khan. Pharmacological advances in cannabinoid-based therapies for pancreatic cancer: preclinical efficacy of CCL-106 and its epimers. ESMO Gastrointestinal Oncology 2025; 9 doi: 10.1016/j.esmogo.2025.100211
|
| 73 |
Fan Zhang, Xiaomin Li, Haisheng Liu, Rongfeng Liu, Zhiguo Zhou, Yi Zhang, Jingli Chen, Ye Tian, Chaohu Pan, Qingju Meng, Yibing Liu. Unexpected favorable outcome to sintilimab monotherapy in a relapse pancreatic ductal adenocarcinoma patient with high tumor mutational burden: a case report. Anti-Cancer Drugs 2022; 33(9) doi: 10.1097/CAD.0000000000001334
|
| 74 |
Dristy Halder, Archi Sundar Paul, Atri Sarker Mumu, Nicholas Cheung, Md. Imtiaz, Mark Christian Guinto, Protup Kumer Sarker. Integrated In silico small molecule drug repurposing approach targeting KRAS G12D therapies for pancreatic ductal adenocarcinoma. In Silico Research in Biomedicine 2026; 2 doi: 10.1016/j.insi.2026.100330
|
| 75 |
Yeonju Cho, Jae W. Lee, Sarah M. Shin, Alexei G. Hernandez, Xuan Yuan, Jowaly Schneider, Jody E. Hooper, Laura D. Wood, Elizabeth M. Jaffee, Atul Deshpande, Won Jin Ho. Computational Modeling of Cellular Influence Delineates Functionally Relevant and Distinct Cellular Neighborhoods in Primary and Metastatic Pancreatic Ductal Adenocarcinoma. Cancer Immunology Research 2026; 14(4) doi: 10.1158/2326-6066.CIR-25-0844
|
| 76 |
Kendelle J. Murphy, Jessie Zhu, Michael Trpceski, Brooke A. Pereira, Paul Timpson, David Herrmann. Focal adhesion kinase priming in pancreatic cancer, altering biomechanics to improve chemotherapy. Biochemical Society Transactions 2022; 50(4) doi: 10.1042/BST20220162
|
| 77 |
Donatella Coradduzza, Teresa Perra, Leonardo Sibono, Andrea Sanna, Maurizio Cossu, Emanuela G. Azara, Francesco Petracca, Roberto Beniamino Madeddu, Maria Rosaria De Miglio, Ciriaco Carru, Massimiliano Grosso, Maria Laura Cossu, Serenella Medici. Diagnostic Stratification of Pancreatic Ductal Adenocarcinoma via Metallomics and Blood-Based Biomarkers. Diagnostics 2025; 15(21) doi: 10.3390/diagnostics15212818
|
| 78 |
Anastasios Gkountakos, Michele Simbolo, Elena Bariani, Aldo Scarpa, Claudio Luchini. Undifferentiated Sarcomatoid Carcinoma of the Pancreas: From Histology and Molecular Pathology to Precision Oncology. International Journal of Molecular Sciences 2022; 23(3) doi: 10.3390/ijms23031283
|
| 79 |
Hassan Aziz, Ye In Christopher Kwon, Andrew Min-Gi Park, Alan Lai, Kerry Yi Chen Lee, Dean Zhang, Yeseo Kwon, Timothy M. Pawlik. Recent advancements in management for noncolorectal, nonneuroendocrine hepatic metastases. Journal of Gastrointestinal Surgery 2024; 28(11) doi: 10.1016/j.gassur.2024.08.012
|
| 80 |
Hanqing Wu, Bo Wang, Li Wang, Yinkai Xue. circular RNAs 0000515 and 0011385 as potential biomarkers for disease monitoring and determining prognosis in pancreatic ductal adenocarcinoma. Oncology Letters 2021; 23(2) doi: 10.3892/ol.2021.13174
|
| 81 |
Ryan Munnings, Peter Gibbs, Belinda Lee. Evolution of Liquid Biopsies for Detecting Pancreatic Cancer. Cancers 2024; 16(19) doi: 10.3390/cancers16193335
|
| 82 |
Shazia Asghar, Shahid Hameed, Najim A Al‐Masoudi, Bahjat Saeed, Amneh Shtaiwi. Design, Synthesis, Docking Studies and Molecular Dynamics Simulation of New 1,3,5‐Triazine Derivatives as Anticancer Agents Selectively Targeting Pancreatic Adenocarcinoma (Capan‐1). Chemistry & Biodiversity 2024; 21(5) doi: 10.1002/cbdv.202400112
|
| 83 |
Michael S. Nelson, Yuming Liu, Helen M. Wilson, Bin Li, Ivan M. Rosado-Mendez, Jeremy D. Rogers, Walter F. Block, Kevin W. Eliceiri. The Tumor Microenvironment. Methods in Molecular Biology 2023; 2614 doi: 10.1007/978-1-0716-2914-7_13
|
| 84 |
Westley Cruces, Tesfay T. Tesfatsion, Giovanni A. Ramirez, Maite L. Docampo-Palacios, Arianna C. Collins, Kyle P. Ray, Prakash G. Jagtap. Synthesis, Characterization, and in vitro Experiments of Saturated Cannabinoids on Pancreatic Ductal Adenocarcinoma Cell Lines (HPAF-II, MIA-PaCa2, ASPC-1, and PANC-1). Natural Product Communications 2025; 20(6) doi: 10.1177/1934578X251348390
|
| 85 |
Rodrigo Paredes de la Fuente, Santiago Sucre, Cristina Ponce, Ahmed Anwer Ali Rattani, Mary Linton B. Peters. Somatic Mutation Profile as a Predictor of Treatment Response and Survival in Unresectable Pancreatic Ductal Adenocarcinoma Treated with FOLFIRINOX and Gemcitabine Nab-Paclitaxel. Cancers 2024; 16(15) doi: 10.3390/cancers16152734
|
| 86 |
Michael D. Zwank, Megan M. Leo, Christine M. Schutzer. Advanced Point-of-Care Ultrasound. 2025; doi: 10.1007/978-3-031-85308-1_10
|
| 87 |
Sooin Byeon, Taymin du Toit‐Thompson, Josef Gillson, Anthony J. Gill, Jaswinder S. Samra, Anubhav Mittal, Sumit Sahni. Heterogeneous tumor microenvironment in pancreatic ductal adenocarcinoma: An emerging role of single‐cell analysis. Cancer Medicine 2023; 12(17) doi: 10.1002/cam4.6407
|
| 88 |
Ayşe Nur Çaldıran, Gizem Gürel, Başak Aru. Evaluation of the Anti-Cancer Efficacy of Cyclooxygenase Inhibition in Combination with Nutrient Starvation on Pancreatic Ductal Adenocarcinoma In Vitro. Turkish Journal of Immunology 2025; 12(3) doi: 10.4274/tji.galenos.2025.29290
|
| 89 |
Davide Busato, Monica Mossenta, Michele Dal Bo, Paolo Macor, Giuseppe Toffoli. The Proteoglycan Glypican-1 as a Possible Candidate for Innovative Targeted Therapeutic Strategies for Pancreatic Ductal Adenocarcinoma. International Journal of Molecular Sciences 2022; 23(18) doi: 10.3390/ijms231810279
|
| 90 |
Zhonglu Ren, Zhuangchang Li, Jie Wang, Yuchen Liu, Lidan Chen, Yuxin Su, Limin Zhao, Xi Liu. Myofibroblastic CAF and Malignant Ductal Cell Crosstalk Drives Epithelial–Mesenchymal Transition and Progression in Pancreatic Ductal Adenocarcinoma via THBS2-SDC/Integrin Axes. International Journal of Molecular Sciences 2026; 27(15) doi: 10.3390/ijms27156951
|
| 91 |
Happy Agarwal, Ryan C. Bynum, Nada Saleh, Danielle Harris, William M. MacCuaig, Vung Kim, Emma J. Sanderson, Isabel S. Dennahy, Rohit Singh, Bahareh Behkam, Jorge G. Gomez‐Gutierrez, Ajay Jain, Barish H. Edil, Lacey R. McNally. Theranostic nanoparticles for detection and treatment of pancreatic cancer. WIREs Nanomedicine and Nanobiotechnology 2024; 16(4) doi: 10.1002/wnan.1983
|
| 92 |
Panagiotis Sarantis, Alexandros Bokas, Adriana Papadimitropoulou, Evangelos Koustas, Stamatios Theocharis, Pavlos Papakotoulas, Dimitrios Schizas, Alexandros Papalampros, Evangelos Felekouras, Athanasios G. Papavassiliou, Michalis V. Karamouzis. Combinatorial Treatment of Tinzaparin and Chemotherapy Can Induce a Significant Antitumor Effect in Pancreatic Cancer. International Journal of Molecular Sciences 2021; 22(13) doi: 10.3390/ijms22137053
|
| 93 |
Hemalatha Kanniyappan, Ruth J. Mathew, Edith Zhan, Meenal Karunanidhi, Saundarya Prithweeraj, Mareeswari Paramasivan, Remya Ampadi Ramachandran, Sreyansh Mamidi, Mathew T. Mathew. A Low-Cost and Sensitive Nanoengineered Electrochemical Biosensor for Early Pancreatic Cancer Prediction: Methodology and ML Models. Biomedical Materials & Devices 2026; doi: 10.1007/s44174-026-00707-z
|
| 94 |
Verena A. Katzke, Yue Chen, Srimanti Dutta, Federico Canzian, Julie Louise Munk Andersen, Agnetha Linn Rostgaard‐Hansen, Léa Bouteille, Vinciane Rebours, Thérèse Truong, Matthias B. Schulze, Benedetta Bendinelli, Valeria Pala, Vittorio Simeon, Rosario Tumino, Carlotta Sacerdote, Roel Vermeulen, P. Martijn Kolijn, Sjoerd G. Elias, Marta Crous‐Bou, Maria‐José Sánchez, Ana Jimenez‐Zabala, José María Huerta, Marcela Guevara, Nick Wareham, Marie Breeur, Mattias Johansson, James Yarmolinsky, Daniele Campa, Rudolf Kaaks. Immune Markers and Risk of Pancreatic Cancer in the European EPIC Cohort. International Journal of Cancer 2026; 159(9) doi: 10.1002/ijc.70581
|
| 95 |
Patrick Reardon, Robert Revere, Simon Coubard, Julian Choi. Patient‐Reported Outcome Measures Following Pancreatectomy for Pancreatic Cancer: A Scoping Review. ANZ Journal of Surgery 2026; doi: 10.1111/ans.70821
|
| 96 |
Casper W.F. van Eijck, Willem de Koning, Fleur van der Sijde, Miranda Moskie, Bas Groot Koerkamp, Marjolein Y.V. Homs, Sjoerd H. van der Burg, Casper H.J. van Eijck, Dana A.M. Mustafa. A multigene circulating biomarker to predict the lack of FOLFIRINOX response after a single cycle in patients with pancreatic ductal adenocarcinoma. European Journal of Cancer 2023; 181 doi: 10.1016/j.ejca.2022.12.024
|
| 97 |
Zachary Hamel, Sierra Sanchez, David Standing, Shrikant Anant. Role of STAT3 in pancreatic cancer. Exploration of Targeted Anti-tumor Therapy 2024; 5(1) doi: 10.37349/etat.2024.00202
|
| 98 |
Valécia de Cassia Mendonça da Costa, Maria do Carmo Alves de Lima, Iranildo José da Cruz Filho, Lília Vieira Galdino, Michelly Cristiny Pereira, Bárbara de Oliveira Silva, Amanda Pinheiro de Barros Albuquerque, Michelle Melgarejo da Rosa, Maira Galdino da Rocha Pitta, Moacyr Jesus Barreto de Melo Rêgo. 5-nitro-thiophene-thiosemicarbazone derivative induces cell death, cell cycle arrest, and phospho-kinase shutdown in pancreatic ductal adenocarcinoma cells. European Journal of Pharmacology 2024; 983 doi: 10.1016/j.ejphar.2024.176963
|
| 99 |
Masato Kamakura, Takeshi Uehara, Mai Iwaya, Shiho Asaka, Shota Kobayashi, Tomoyuki Nakajima, Yasuhiro Kinugawa, Tadanobu Nagaya, Takahiro Yoshizawa, Akira Shimizu, Hiroyoshi Ota, Takeji Umemura. LGR5 expression and clinicopathological features of the invasive front in the fat infiltration area of pancreatic cancer. Diagnostic Pathology 2022; 17(1) doi: 10.1186/s13000-022-01203-w
|
| 100 |
Jin-Lei Wang, Xiang Li, Jia-Ru Fan, Jia-Ping Yan, Ze-Mao Gong, Yue Zhao, Dong-Mei Wang, Li Ma, Na Ma, Diao-Mei Guo, Lian-Sheng Ma. Integrity of the editing and publishing process is the basis for improving an academic journal’s Impact Factor. World Journal of Gastroenterology 2022; 28(43): 6168-6202 doi: 10.3748/wjg.v28.i43.6168
|
| 101 |
Hunter D. Reavis, Aditi H. Chaubey, Amanda L. Smythers, Arwen A. Tisdale, Amanda Tracz, Alphonse N. Dimeck, Kathryn E. Maraszek, Eduardo Cortes Gomez, Joao A. Paulo, Subhamoy Dasgupta, Steven P. Gygi, Michael E. Feigin. Alprazolam Reduces Inflammatory Cytokine Production in Pancreatic Cancer–Associated Fibroblasts. Cancer Research Communications 2026; 6(5) doi: 10.1158/2767-9764.CRC-25-0472
|
| 102 |
Ben O’Leary, Heath Skinner, Jonathan D Schoenfeld, Lisa Licitra, Christophe Le Tourneau, Christina Esdar, Andreas Schroeder, Satu Salmio, Amanda Psyrri. Evasion of apoptosis and treatment resistance in squamous cell carcinoma of the head and neck. Cancer Treatment Reviews 2024; 129 doi: 10.1016/j.ctrv.2024.102773
|
| 103 |
Pragya Pragya, Renu Yadav, Abdul Aleem Shaik Gadda, Jac Fredo Agastinose Ronickom. Machine Learning-Driven Optimization of PDAC Therapeutic Prediction of Pharmacokinetics Profiles. 2025 12th International Conference on Soft Computing & Machine Intelligence (ISCMI) 2025; doi: 10.1109/ISCMI67495.2025.11358565
|
| 104 |
Abigail C. Cornwell, Arwen A. Tisdale, Swati Venkat, Kathryn E. Maraszek, Abdulrahman A. Alahmari, Anthony George, Kristopher Attwood, Madison George, Donald Rempinski, Janusz Franco-Barraza, Mukund Seshadri, Mark D. Parker, Eduardo Cortes Gomez, Christos Fountzilas, Edna Cukierman, Nina G. Steele, Michael E. Feigin. Lorazepam Stimulates IL6 Production and Is Associated with Poor Survival Outcomes in Pancreatic Cancer. Clinical Cancer Research 2023; 29(18) doi: 10.1158/1078-0432.CCR-23-0547
|
| 105 |
Mariana Viso, Karthik Rajkumar, Anna Bianchi, Bhumi Suthar, Neil Kumar, David Oliver, Mya Collins, Jashodeep Datta, Ashutosh Agarwal. Immune-driven stromal inflammation in pancreatic cancer within a microfluidic platform. Biofabrication 2026; 18(3) doi: 10.1088/1758-5090/ae7b09
|
| 106 |
Yalçın ERZURUMLU. Katlanmamış Protein Yanıtı Sinyal Yolunun IRE1α Kolunun Baskılanmasının PANC-1 Pankreatik Duktal Adenokarsinoma Hücrelerinin Tümörijenik Özellikleri Üzerindeki Etkilerinin İncelenmesi. Süleyman Demirel Üniversitesi Sağlık Bilimleri Dergisi 2022; 13(1) doi: 10.22312/sdusbed.1003140
|
| 107 |
Sara Escalera-Anzola, Maria Rosado, Yuchen Yang, Daniel Parra-Sanchez, Carolina San Pedro-Liberal, Pilar Acedo. Breakthroughs in nanoparticle-based strategies for pancreatic cancer therapy. Biochemical Pharmacology 2025; 232 doi: 10.1016/j.bcp.2024.116685
|
| 108 |
Gitika Thakur, Raj Kumar, Saet-Byul Kim, Sang-Yeob Lee, Sung-Lim Lee, Gyu-Jin Rho. Therapeutic Status and Available Strategies in Pancreatic Ductal Adenocarcinoma. Biomedicines 2021; 9(2) doi: 10.3390/biomedicines9020178
|
| 109 |
Aaron Galindo-Vega, Vilma Maldonado-Lagunas, Irma B. Mitre-Aguilar, Jorge Melendez-Zajgla. Tumor Microenvironment Role in Pancreatic Cancer Stem Cells. Cells 2023; 12(12) doi: 10.3390/cells12121560
|
| 110 |
S. Mohammed Zaidh, Hariharan Thirumalai Vengateswaran, Mohammad Habeeb, Kiran Balasaheb Aher, Girija Balasaheb Bhavar, N. Irfan, K N V Chenchu Lakshmi. Network pharmacology and AI in cancer research uncovering biomarkers and therapeutic targets for RALGDS mutations. Scientific Reports 2025; 15(1) doi: 10.1038/s41598-025-91568-x
|
| 111 |
Rana Alfardan. Effect of Small Nuclear RNA 64 (SNORA64) on Apoptosis Regulator Genes in Pancreatic Cancer in Vitro. F1000Research 2026; 15 doi: 10.12688/f1000research.173746.2
|
| 112 |
G. Ulus, EN Özbek, H. Yılmaz, E. Keselik, M. Sarıcaoğlu, S. Akyol Bahçeci, E. İşel, B. Debeleç Bütüner, G. Yetik Anacak, AT Koparal. Borax pentahydrate as a promising boron-based angiogenesis inhibitor. Journal of Trace Elements in Medicine and Biology 2025; 89 doi: 10.1016/j.jtemb.2025.127640
|
| 113 |
Simran Arjani, Pedro F Saint-Maurice, Sachelly Julián-Serrano, Guido Eibl, Rachael Stolzenberg-Solomon. Body Mass Index Trajectories Across the Adult Life Course and Pancreatic Cancer Risk. JNCI Cancer Spectrum 2022; 6(6) doi: 10.1093/jncics/pkac066
|
| 114 |
Mohamedraed Elshami, Omkar S. Pawar, Jordan M. Winter. Cure probabilities of patients with pancreatic ductal adenocarcinoma in the United States: A Surveillance, Epidemiology, and End Results–based analysis. Surgery 2026; 195 doi: 10.1016/j.surg.2026.110223
|
| 115 |
Gurkaranjot Singh, Drew Kutcher, Rajeshwar Lally, Vikrant Rai. Targeting Neoantigens in Pancreatic Ductal Adenocarcinoma. Cancers 2024; 16(11) doi: 10.3390/cancers16112101
|
| 116 |
Feilong Zhou, Kailu Yang, Haoran Wang, Minghui Han, Dongping Zhang, Jie Wang, Han Wang, Yi Wang, Fengcongzhe Gong, Hao Zheng, Yanqin Liu, Jiliang Zhao, Meiyi Xu, Youjia Cao, Cuizhu Zhang. Oncolytic herpes simplex virus reprograms cancer-associated fibroblasts to enhance antitumor immunity in pancreatic cancer. Molecular Therapy Oncology 2025; 33(3) doi: 10.1016/j.omton.2025.201021
|
| 117 |
Ingyu Bahng. CCR-CCL axes as key upstream influencers of pancreatic ductal adenocarcinoma: CCR2–CCL2, CCR5–CCL5, CCR4–CCL17/22, CCR6–CCL20, CCR7–CCL19/21. Frontiers in Immunology 2026; 17 doi: 10.3389/fimmu.2026.1713123
|
| 118 |
Chi Soo Kang. Development of Antibody and Antibody Fragment-Based Radiopharmaceuticals for Cancer Imaging and Therapy. Nuclear Medicine and Molecular Imaging 2026; 60(3) doi: 10.1007/s13139-025-00969-3
|
| 119 |
H Shafeeq AHMED. BEYOND TRADITIONAL TOOLS: EXPLORING CONVOLUTIONAL NEURAL NETWORKS AS INNOVATIVE PROGNOSTIC MODELS IN PANCREATIC DUCTAL ADENOCARCINOMA. Arquivos de Gastroenterologia 2024; 61 doi: 10.1590/s0004-2803.24612023-117
|
| 120 |
Sandeep Singh, Rajeev Kumar Sharma, R. Ramajayam. Bis-pyrazole as receptor interacting protein 1 kinase inhibitor: Synthesis, preliminary biological evaluation against pancreatic cancer cell line and its docking studies. Results in Chemistry 2024; 7 doi: 10.1016/j.rechem.2024.101447
|
| 121 |
Donatella Delle Cave. Emerging Therapeutic Options in Pancreatic Cancer Management. International Journal of Molecular Sciences 2024; 25(3) doi: 10.3390/ijms25031929
|
| 122 |
Gehan Botrus, Richard M. Miller, Pedro Luiz Serrano Uson Junior, Geoffrey Kannan, Haiyong Han, Daniel D. Von Hoff. Increasing Stress to Induce Apoptosis in Pancreatic Cancer via the Unfolded Protein Response (UPR). International Journal of Molecular Sciences 2022; 24(1) doi: 10.3390/ijms24010577
|
| 123 |
Chaosheng Peng, Juan Wang, Shu Wang, Yan Zhao, Haoyuan Wang, Yuhao Wang, Yuxuan Ma, Jianjun Yang. Endoplasmic Reticulum Stress: Triggers Microenvironmental Regulation and Drives Tumor Evolution. Cancer Medicine 2025; 14(5) doi: 10.1002/cam4.70684
|
| 124 |
Carla Mottini, Luca Cardone. Beyond the Genomic Mutation: Rethinking the Molecular Biomarkers of K-RAS Dependency in Pancreatic Cancers. International Journal of Molecular Sciences 2020; 21(14) doi: 10.3390/ijms21145023
|
| 125 |
Gaurav Sheth, Shailesh R. Shah, Prabal Sengupta, Tushar Jarag, Sabbirhusen Chimanwala, Kalapatapu V. V. M. Sairam, Vaibhav Jain, Rashmi Talwar, Avinash Dhanave, Mehul Raviya, Harendra Jha, Rajasekhar Reddy Chilakala, Trinadha Rao Chitturi. Strategic Design and Development of Indole‐Based Compounds as Potent Malic Enzyme 3 Inhibitors for Pancreatic Tumor Therapy. ChemMedChem 2025; 20(23) doi: 10.1002/cmdc.202500470
|
| 126 |
Jin Yan, Huiyi Ou, Shuai Wang, Kaizhou Jin, Xianjun Yu, Weiding Wu. Overcoming multidimensional immunotherapy resistance in PDAC: from microenvironment to clinic. Frontiers in Immunology 2026; 17 doi: 10.3389/fimmu.2026.1782960
|
| 127 |
Friederike V. Opitz, Lena Haeberle, Alexandra Daum, Irene Esposito. Tumor Microenvironment in Pancreatic Intraepithelial Neoplasia. Cancers 2021; 13(24) doi: 10.3390/cancers13246188
|
| 128 |
Manish Shukla, Jai Chand Patel, Meenakshi Shukla. Identification of key genes and pathways in the following pancreatic ductal adenocarcinoma (PDAC) using integrated bioinformatics analysis. Gastroenterology & Endoscopy 2025; 3(3) doi: 10.1016/j.gande.2025.05.004
|
| 129 |
Priyanka Narad, Romasha Gupta, Sudeepti Kulshrestha, Abhishek Sengupta. Systems Biology Approaches: Prevention, Diagnosis, and Understanding Mechanisms of Complex Diseases. 2024; doi: 10.1007/978-981-99-9462-5_17
|
| 130 |
Bhaskar Banerjee, Bobby Solanki, Rajaneesh Kumar Verma, Nidhi Jain, Tarun Yadav, Mustafa A. Alheetyc, M. Z. A. Yahya, Munendra Singh, Vinay Kumar Verma, Ram Chandra Singh. Synthesis, Characterization, and Computational Studies of Organoselenium Compounds for Bioactivity Assessment Against Pancreatic Ductal Adenocarcinoma. Macromolecular Symposia 2025; 414(1) doi: 10.1002/masy.202400177
|
| 131 |
Julien Taieb, Thomas Seufferlein, Michele Reni, Daniel H. Palmer, John A. Bridgewater, Antonio Cubillo, Gerald W. Prager, Alice Vermeire, Fabienne Hédouin-Biville, Zhaoyang Teng, Teresa Macarulla. Treatment sequences and prognostic/predictive factors in metastatic pancreatic ductal adenocarcinoma: univariate and multivariate analyses of a real-world study in Europe. BMC Cancer 2023; 23(1) doi: 10.1186/s12885-023-11377-1
|
| 132 |
Maria Mortoglou, Mutian Lian, Francesc Miralles, D. Alwyn Dart, Pinar Uysal-Onganer. miR-210 Mediated Hypoxic Responses in Pancreatic Ductal Adenocarcinoma. ACS Omega 2024; 9(48) doi: 10.1021/acsomega.4c08947
|
| 133 |
Beyza Ecem Oz Bedir, Tuba Ozdemir Sanci, Emine Terzi, Elif Ercan, Nour El‐Huda Daoud, Ulviye Acar Çevik. Design, Synthesis, and In Vitro Biological Assessment of Novel Benzimidazole and Hydrazone Derivatives Against Pancreatic Cancer and Melanoma Cells. Chemical Biology & Drug Design 2026; 107(6) doi: 10.1111/cbdd.70349
|
| 134 |
Nagabhishek Sirpu Natesh, Brianna M. White, Maia M. C. Bennett, Metin Uz, Rakhee Rathnam Kalari Kandy, Surinder K. Batra, Surya K. Mallapragada, Satyanarayana Rachagani. Emerging Role of miR-345 and Its Effective Delivery as a Potential Therapeutic Candidate in Pancreatic Cancer and Other Cancers. Pharmaceutics 2021; 13(12) doi: 10.3390/pharmaceutics13121987
|
| 135 |
Joanna Jazowiecka-Rakus, Aleksander Sochanik, Agata Hadryś, Wojciech Fidyk, Ewa Chmielik, Masmudur M. Rahman, Grant McFadden. Combination of LIGHT (TNFSF14)-Armed Myxoma Virus Pre-Loaded into ADSCs and Gemcitabine in the Treatment of Experimental Orthotopic Murine Pancreatic Adenocarcinoma. Cancers 2022; 14(8) doi: 10.3390/cancers14082022
|
| 136 |
Panagiotis Sarantis, Michalis V. Karamouzis. The impact of thromboprophylaxis with LMWHs on the survival of patients with pancreatic cancer. Thrombosis Research 2022; 213 doi: 10.1016/j.thromres.2022.02.004
|
| 137 |
Shaimaa Elzamly, Mouaz Alsawas, Mahmoud M.G. Yousef, Dan Zhao, Matthew HG. Katz, Laura R. Prakash, Hua Wang, Ziang Li, Robert A. Wolff, Anirban Maitra, Huamin Wang. Clinicopathologic Characteristics of Brain Metastasis of Pancreatic Ductal Adenocarcinoma. American Journal of Surgical Pathology 2026; 50(1) doi: 10.1097/PAS.0000000000002470
|
| 138 |
Prachi Bhatt, Jared Hirsch, Paul Cockrum, George Kim, Gabriela Dieguez. he Effects of Adverse Events and Associated Costs on Value-Based Care for Metastatic Pancreatic Ductal Adenocarcinoma. Journal of Health Economics and Outcomes Research 2024; doi: 10.36469/jheor.2024.124367
|
| 139 |
Shuai Liu, Hua Zhong, Jingjing Zhu, Yong Wu, Youping Deng, Lang Wu. Regulome‐wide association study identifies genetically driven accessible regions associated with pancreatic cancer risk. International Journal of Cancer 2024; 154(4) doi: 10.1002/ijc.34761
|
| 140 |
Vassiliki Tarara, Evangelos Karamitrousis. Use of histone deacetylase inhibitors (HDACis) in pancreatic ductal adenocarcinoma (PDAC): A narrative review. Forum of Clinical Oncology 2025; doi: 10.2478/fco-2024-0007
|
| 141 |
Marzia Conte, Valentina Cauda. Multimodal Therapies against Pancreatic Ductal Adenocarcinoma: A Review on Synergistic Approaches toward Ultimate Nanomedicine Treatments. Advanced Therapeutics 2022; 5(11) doi: 10.1002/adtp.202200079
|
| 142 |
Macy Marie Payne, Ivina Mali, Tej B. Shrestha, Matthew T. Basel, Sarah Timmerman, Marla Pyle, Jan Sebek, Punit Prakash, Stefan H. Bossmann. T1-mapping characterization of two tumor types. Biophysical Reports 2024; 4(2) doi: 10.1016/j.bpr.2024.100157
|
| 143 |
Muhammad Ibtsaam Qadir, Jackson A. Baril, Michele T. Yip-Schneider, Duane Schonlau, Thi Thanh Thoa Tran, C. Max Schmidt, Fiona R. Kolbinger, Dhiya Al-Jumeily OBE. Artificial intelligence in pancreatic intraductal papillary mucinous neoplasm imaging: A systematic review. PLOS Digital Health 2025; 4(7) doi: 10.1371/journal.pdig.0000920
|
| 144 |
Shruti Gupta, Atul Kumar, Kiran Kumar Tejavath. Unfolding antifungals: as a new foe to pancreatic ductal adenocarcinoma—a mini-review. Molecular Biology Reports 2021; 48(3) doi: 10.1007/s11033-021-06318-9
|
| 145 |
Reetu Mukherji, Ali Alqahtani, Harrison D Winters, Benjamin A Weinberg. Use of Circulating Tumour DNA to Assess Minimal Residual Disease in Gastrointestinal Cancers. Oncology & Haematology 2022; 18(1) doi: 10.17925/OHR.2022.18.1.26
|
| 146 |
Shunsuke Imamura, Takeshi Uehara, Mai Iwaya, Shiho Asaka, Shinsuke Sugenoya, Hiroshi Sawaguchi, Takahiro Yoshizawa, Yasuhiro Kuraishi, Tomoyuki Nakajima, Shotaro Komamura, Akira Nakamura, Yugo Iwaya, Akira Shimizu, Yuji Soejima, Hiroyoshi Ota, Tadanobu Nagaya.
CXCL12
Expression and Clinicopathological Features at the Invasive Front of Pancreatic Cancer
. Clinical Medicine Insights: Oncology 2026; 20 doi: 10.1177/11795549261473797
|
| 147 |
Grace J. Rilee, Senthil K. Radhakrishnan, Guang-Yu Yang, Jiong Li. The Role of FOSL1 in Inflammatory Bowel Disease (IBD) Pathogenesis and IBD-Associated Tumorigenesis. Biomolecules 2026; 16(5) doi: 10.3390/biom16050647
|
| 148 |
Yongjie Zhu, Ruipu Sun, Jiawei Fan, Haiyan Ma, Bin Sun. CSF1-CAR Specifically Targets CSF1R+ Pancreatic Cancer Cells and Tumor-Associated Macrophages. Journal of Immunotherapy 2025; 48(7) doi: 10.1097/CJI.0000000000000563
|
| 149 |
Stavros P. Papadakos, Nikolaos Dedes, Nikolina Gkolemi, Nikolaos Machairas, Stamatios Theocharis. The EPH/Ephrin System in Pancreatic Ductal Adenocarcinoma (PDAC): From Pathogenesis to Treatment. International Journal of Molecular Sciences 2023; 24(3) doi: 10.3390/ijms24033015
|
| 150 |
Maedeh Shahrabi, Asma Aliparast, Fatemeh Moosavi, Amirsajad Jafari, Negar Firouzabadi, Omidreza Firuzi. Sertraline Has Anticancer Effects and Enhances the Cytotoxicity of Chemotherapeutic Agents Against Pancreatic Cancer Cells. Archiv der Pharmazie 2026; 359(6) doi: 10.1002/ardp.70290
|
| 151 |
Faithlore P. Gardner, Zev A. Wainberg, Christos Fountzilas, Nathan Bahary, Mark S. Womack, Teresa Macarulla, Ignacio Garrido-Laguna, Patrick M. Peterson, Erkut Borazanci, Melissa Johnson, Matteo Ceccarelli, Uwe Pelzer. Results of a Randomized, Double-Blind, Placebo-Controlled, Phase 1b/2 Trial of Nabpaclitaxel + Gemcitabine ± Olaratumab in Treatment-Naïve Participants with Metastatic Pancreatic Cancer. Cancers 2024; 16(7) doi: 10.3390/cancers16071323
|
| 152 |
Wendy Muircroft, Fraser Welsh. A Review of Quality of Life Experienced by Patients Following Surgery for Pancreatic Cancer. Cancers 2025; 17(16) doi: 10.3390/cancers17162602
|
| 153 |
Adi Jabarin, Guy Shtar, Valeria Feinshtein, Eyal Mazuz, Bracha Shapira, Lior Rokach, Shimon Ben-Shabat. Investigating the anticancer activity of eravacycline in pancreatic cancer via target-based deep learning and experimental validation. Briefings in Bioinformatics 2026; 27(4) doi: 10.1093/bib/bbag353
|
| 154 |
Amanda Gustafsson, Hedvig Svedberg, Sara S. Rinne, Filippa Bertilsson, Ram Kumar Selvaraju, Anja C. Lundgren Mortensen, Cecilia Lindskog, Marika Nestor. [177Lu]Lu-AKIR001 for CD44v6-Positive Pancreatic Cancer: Preclinical Efficacy and Combination Strategies. Journal of Nuclear Medicine 2026; 67(9) doi: 10.2967/jnumed.125.271705
|
| 155 |
Yukun Huang, Yu Chen, Songlei Zhou, Laozhi Xie, Kaifan Liang, Jianpei Xu, Qian Zhang, Huan Chen, Dayuan Wang, Qingxiang Song, Gan Jiang, Ni Mei, Fenfen Ma, Huiping Lu, Xiaoling Gao, Jun Chen. Synthetically Lethal Biomimetic Nutri-hijacker Hitchhikes and Reprograms KRAS Mutation-Driven Metabolic Addictions for Pancreatic Ductal Adenocarcinoma Treatment. ACS Nano 2023; 17(14) doi: 10.1021/acsnano.3c04069
|
| 156 |
Ana Bogut, Bojan Stojanovic, Marina Jovanovic, Milica Dimitrijevic Stojanovic, Nevena Gajovic, Bojana S. Stojanovic, Goran Balovic, Milan Jovanovic, Aleksandar Lazovic, Milos Mirovic, Milena Jurisevic, Ivan Jovanovic, Violeta Mladenovic. Galectin-1 in Pancreatic Ductal Adenocarcinoma: Bridging Tumor Biology, Immune Evasion, and Therapeutic Opportunities. International Journal of Molecular Sciences 2023; 24(21) doi: 10.3390/ijms242115500
|
| 157 |
Elham Karimi, Niloufar Sadat Kalaki, Seyed Mohammad Akrami. Identifying Hub Genes and Pathways in Pancreatic Ductal Adenocarcinoma (PAAD): A comprehensive in silico study. Biochemistry and Biophysics Reports 2025; 41 doi: 10.1016/j.bbrep.2025.101921
|
| 158 |
Mahmut Mijit, Randall Wireman, Lee Armstrong, Silpa Gampala, Zonera Hassan, Christian Schneeweis, Guenter Schneider, Chi Zhang, Melissa L. Fishel, Mark R. Kelley. RelA Is an Essential Target for Enhancing Cellular Responses to the DNA Repair/Ref-1 Redox Signaling Protein and Restoring Perturbated Cellular Redox Homeostasis in Mouse PDAC Cells. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.826617
|
| 159 |
Shang Wu, Jia Feng, Ting Wang, Kyler Hwa, Selina Kao, Ying Xiao, Dongfang Yang, Xinjian Li, Zebang Li, Ryan Liu, Yancheng Liu, Yikai Lu, Xiaoxu Zhou, Yifei Liu, Chiung-Kuei Huang, Shaolei Lu. Ras Homolog Family Member V Promotes Pancreatic Ductal Adenocarcinoma Progression. The American Journal of Pathology 2026; 196(5) doi: 10.1016/j.ajpath.2026.02.002
|
| 160 |
Ranjit S. Jadhav, Akshada Koparde, Akshay B. Kadam, Kunal Agam Kanaujia. Mesenchymal stem cell-derived exosome-inspired nanoformulations: a new frontier in targeted cancer therapy. International Journal of Pharmaceutics 2026; 698 doi: 10.1016/j.ijpharm.2026.126929
|
| 161 |
Yong-Qiang Hua, Ke Zhang, Jie Sheng, Zhou-Yu Ning, Ye Li, Wei-dong Shi, Lu-Ming Liu. NUCB1 Suppresses Growth and Shows Additive Effects With Gemcitabine in Pancreatic Ductal Adenocarcinoma via the Unfolded Protein Response. Frontiers in Cell and Developmental Biology 2021; 9 doi: 10.3389/fcell.2021.641836
|
| 162 |
Sofia M. Sousa, Helena Branco, Amir Avan, Andreia Palmeira, Luca Morelli, Lúcio L. Santos, Elisa Giovannetti, M. Helena Vasconcelos, Cristina P. R. Xavier. Darifenacin: a promising chitinase 3-like 1 inhibitor to tackle drug resistance in pancreatic ductal adenocarcinoma. Cancer Chemotherapy and Pharmacology 2024; 94(4) doi: 10.1007/s00280-024-04712-1
|
| 163 |
Spas Dimitrov Markov, Thomas C. Caffrey, Kelly A. O'Connell, James A. Grunkemeyer, Simon Shin, Ryan Hanson, Prathamesh P. Patil, Surendra K. Shukla, Daisy Gonzalez, Ayrianne J. Crawford, Krysten E. Vance, Ying Huang, Kirsten C. Eberle, Prakash Radhakrishnan, Paul M. Grandgenett, Pankaj K. Singh, Ragupathy Madiyalakan, Tracy R. Daniels-Wells, Manuel L. Penichet, Christopher F. Nicodemus, Jill A. Poole, Elizabeth M. Jaffee, Michael A. Hollingsworth, Kamiya Mehla. IgE-Based Therapeutic Combination Enhances Antitumor Response in Preclinical Models of Pancreatic Cancer. Molecular Cancer Therapeutics 2021; 20(12) doi: 10.1158/1535-7163.MCT-21-0368
|
| 164 |
Ghada Salah, Manar Obada, Dina Sweed, Ibrahim Abdelkader Salama, Ashraf Khalil, Shimaa Abdelsattar. Diagnostic and prognostic significance of tissue lncRNA HOTAIR and hexokinase 2 mRNA expression in patients with pancreatic ductal adenocarcinoma. Egyptian Liver Journal 2024; 14(1) doi: 10.1186/s43066-023-00308-1
|
| 165 |
Lei Feng, Xiaojuan Tang, Zhen You. Undifferentiated sarcomatoid carcinoma of the pancreas-a single-institution experience with 23 cases. BMC Cancer 2024; 24(1) doi: 10.1186/s12885-024-11988-2
|
| 166 |
Jiarui Ma, Vipul Bhardwaj, Peter E. Lobie, Vijay Pandey. Metabolic plasticity in pancreatic ductal adenocarcinoma progression and response to treatment. Molecular Cancer 2026; 25(1) doi: 10.1186/s12943-026-02620-x
|
| 167 |
Gonçalo Mesquita, Aurélien Haustrate, Adriana Mihalache, Benjamin Soret, Clément Cordier, Emilie Desruelles, Erika Duval, Zoltan Pethö, Natalia Prevarskaya, Albrecht Schwab, V’yacheslav Lehen’kyi. TRPV6 Channel Is Involved in Pancreatic Ductal Adenocarcinoma Aggressiveness and Resistance to Chemotherapeutics. Cancers 2023; 15(24) doi: 10.3390/cancers15245769
|
| 168 |
Nnenna Elebo, Mafuno Grace Mpinganjira, Pavan Baichan, John Devar, Jones Omoshoro-Jones, Joel Msafiri Francis, Martin Smith, Ekene Emmanuel Nweke. The need for research targeting the link between occupational carcinogens and hepatopancreatobiliary cancers in Africa: A systematic review. Translational Oncology 2024; 47 doi: 10.1016/j.tranon.2024.102036
|
| 169 |
Bahareh Soleimanpour, Juan Jose Diaz Mochon, Salvatore Pernagallo. Amplification-Free Testing of microRNA Biomarkers in Cancer. Cancers 2025; 17(16) doi: 10.3390/cancers17162715
|
| 170 |
Benedetta Ferrara, Erica Dugnani, Antonio Citro, Marco Schiavo Lena, Paolo Marra, Paolo Riccardo Camisa, Martina Policardi, Tamara Canu, Antonio Esposito, Claudio Doglioni, Lorenzo Piemonti. Establishment of a Transplantation Model of PDAC-Derived Liver Metastases. Annals of Surgical Oncology 2024; 31(9) doi: 10.1245/s10434-024-15514-3
|
| 171 |
Ranjit K. Harwansh, Junainah Abd Hamid, Pranay Wal, Rohitas Deshmukh, Pratap Kumar Patra, Amin Gasmi. Recent Advancement in Drug Targeting Therapies in the Treatment of Pancreatic Cancer. Current Pharmaceutical Design 2025; 31(31) doi: 10.2174/0113816128334659241223113743
|
| 172 |
Simona Carlomagno, Chiara Setti, Fulvia Ortolani, Simona Sivori. Pancreatic ductal adenocarcinoma microenvironment: Soluble factors and cancer associated fibroblasts as modulators of NK cell functions. Immunology Letters 2024; 269 doi: 10.1016/j.imlet.2024.106898
|
| 173 |
Josiah McAllister, Saber Amin, Chi Lin. Association of Facility Type With Overall Survival in Patients with Nonsurgically Managed Pancreatic Cancer. Future Oncology 2022; 18(10) doi: 10.2217/fon-2021-0986
|
| 174 |
Carlos P. Jara, Al-Murtadha Al-Gahmi, Audrey Lazenby, Michael A. Hollingsworth, Mark A. Carlson. Selective epithelial expression of KRASG12D in the Oncopig pancreas drives ductal proliferation and desmoplasia that is accompanied by an immune response. Scientific Reports 2025; 15(1) doi: 10.1038/s41598-025-87178-2
|
| 175 |
Yixing Kang, Xiangwen Xu, Jikui Liu.
System Analysis Based on Pancreatic Cancer Progression Identifies BRINP2 as a Novel Prognostic Biomarker
. Critical Reviews in Eukaryotic Gene Expression 2023; 33(7) doi: 10.1615/CritRevEukaryotGeneExpr.2023048337
|
| 176 |
Yang Wu, Tian Li, Runbing Zhang, Tingting Shi, Shunna Wang, Lingling Zhu, Yani Zhang, Xiaofeng Zheng, Xiaohui Yu, Jiucong Zhang. Establishment of nomogram of early death in elderly pancreatic cancer patients with liver metastasis. Discover Oncology 2025; 16(1) doi: 10.1007/s12672-025-02059-4
|
| 177 |
Tanmay Kulkarni, Sreya Banik, Debabrata Mukhopadhyay, Hani Babiker, Santanu Bhattacharya. Tumor-Treating Fields Alter Nanomechanical Properties of Pancreatic Ductal Adenocarcinoma Cells Co-Cultured with Extracellular Matrix. Journal of Functional Biomaterials 2025; 16(5) doi: 10.3390/jfb16050160
|
| 178 |
Investigating underlying molecular mechanisms, signaling pathways, emerging therapeutic approaches in pancreatic cancer. Frontiers in Oncology 2024; 14 doi: 10.3389/fonc.2024.1427802
|
| 179 |
Cesar B. Aparicio-Lopez, Sarah Timmerman, Gabriella Lorino, Tatiana Rogers, Marla Pyle, Tej B. Shrestha, Matthew T. Basel. Thermosensitive Liposomes for Gemcitabine Delivery to Pancreatic Ductal Adenocarcinoma. Cancers 2024; 16(17) doi: 10.3390/cancers16173048
|
| 180 |
Lei Zhao, Yaming Cao. PD-L1 Expression Level Displays a Positive Correlation with Immune Response in Pancreatic Cancer. Disease Markers 2020; 2020 doi: 10.1155/2020/8843146
|
| 181 |
Alejandro A. Puchol Tarazona, Alexander Schinagl, Irina Mirkina, Gregor Rossmueller, Randolf J. Kerschbaumer, Friedmund Bachmann, Michael Thiele. Pretargeted Radioimmunotherapy with the Novel Anti-oxMIF/HSG Bispecific Antibody ON105 Results in Significant Tumor Regression in Murine Models of Cancer. Molecular Cancer Therapeutics 2024; 23(9) doi: 10.1158/1535-7163.MCT-24-0083
|
| 182 |
Amogh Verma, Jaskirat Singh, Rodrigue Ndabashinze, Sanjit Sah, Manu Pant, Mahalaqua N. Khatib, Mahendra P. Singh, Quazi S. Zahiruddin, Sarvesh Rustagi. The future of pancreatic cancer prognosis: machine learning and radiomics integration. International Journal of Surgery Open 2024; 62(5) doi: 10.1097/IO9.0000000000000158
|
| 183 |
Xue Wang, Zhan Shi, Jiali Luo, Yiqing Zeng, Liangcan He, Libin Chen, Jianting Yao, Tao Zhang, Pintong Huang. Ultrasound improved immune adjuvant delivery to induce DC maturation and T cell activation. Journal of Controlled Release 2022; 349 doi: 10.1016/j.jconrel.2022.06.054
|
| 184 |
Salomé Araujo-Abad, Antonio Manresa-Manresa, Enrique Rodríguez-Cañas, María Fuentes- Baile, Pilar García-Morales, Ricardo Mallavia, Miguel Saceda, Camino de Juan Romero. New therapy for pancreatic cancer based on extracellular vesicles. Biomedicine & Pharmacotherapy 2023; 162 doi: 10.1016/j.biopha.2023.114657
|
| 185 |
Bahareh Hassani, Zeinab Attar, Negar Firouzabadi. The renin-angiotensin-aldosterone system (RAAS) signaling pathways and cancer: foes versus allies. Cancer Cell International 2023; 23(1) doi: 10.1186/s12935-023-03080-9
|
| 186 |
Seyed Mostafa Rahimi, Hamid Reza Nouri. Computational design and molecular characterization of a multi-epitope peptide vaccine targeting pancreatic cancer. Journal of Genetic Engineering and Biotechnology 2026; 24(2) doi: 10.1016/j.jgeb.2026.100670
|
| 187 |
Falguni Saraf, Manas Ranjan Purohit, Lakshmisundaram Raman, Henu Kumar Verma, L.V.K.S. Bhaskar. Targeting DNA Repair Mechanisms, Tumor Genetics, and Signaling Pathways. 2026; doi: 10.1016/B978-0-443-43976-6.00017-X
|
| 188 |
Karel Hořejší, Chunsheng Jin, Zuzana Vaňková, Robert Jirásko, Ondřej Strouhal, Bohuslav Melichar, Susann Teneberg, Michal Holčapek. Comprehensive characterization of complex glycosphingolipids in human pancreatic cancer tissues. Journal of Biological Chemistry 2023; 299(3) doi: 10.1016/j.jbc.2023.102923
|
| 189 |
Juan Zhang, Hongxi Xu, Yulin Wu, William Chi Shing Cho, Yang Li, Peiyao Ren, Yanfang Xian, Zhixiu Lin. Brusatol increases chemotherapeutic drug efficacy in pancreatic ductal adenocarcinoma by suppressing Nrf2 signaling. Acta Materia Medica 2024; 3(3) doi: 10.15212/AMM-2024-0016
|
| 190 |
Salona Kar, Simran Panda, Swayambara Mishra, Amlan Priyadarshee Mohapatra, Shantibhusan Senapati. 3D Bioprinting in Cancer Applications. 2025; doi: 10.1016/B978-0-443-26518-1.00008-2
|
| 191 |
Hadas Volkov, Rani Shlayem, Noam Shomron. Deciphering the Diagnostic Potential of Small Non-Coding RNAs for the Detection of Pancreatic Ductal Adenocarcinoma Through Liquid Biopsies. International Journal of Molecular Sciences 2025; 26(16) doi: 10.3390/ijms26168108
|
| 192 |
Milica Dimitrijevic Stojanovic, Bojan Stojanovic, Ivan Radosavljevic, Vojin Kovacevic, Ivan Jovanovic, Bojana S. Stojanovic, Nikola Prodanovic, Vesna Stankovic, Miodrag Jocic, Marina Jovanovic. Galectin-3’s Complex Interactions in Pancreatic Ductal Adenocarcinoma: From Cellular Signaling to Therapeutic Potential. Biomolecules 2023; 13(10) doi: 10.3390/biom13101500
|
| 193 |
Emily A. Henderson, Abby Ivey, Soo Jeon Choi, Stell Santiago, Dudley McNitt, Tracy W. Liu, Slawomir Lukomski, Brian A. Boone. Group A streptococcal collagen-like protein 1 restricts tumor growth in murine pancreatic adenocarcinoma and inhibits cancer-promoting neutrophil extracellular traps. Frontiers in Immunology 2024; 15 doi: 10.3389/fimmu.2024.1363962
|
| 194 |
Changhoon Yoo, Angela Lamarca, Hye Jin Choi, Arndt Vogel, Michael J Pishvaian, Lipika Goyal, Makoto Ueno, Angela Märten, Michael Teufel, Lijiang Geng, Chigusa Morizane. Brightline-2: a phase IIa/IIb trial of brigimadlin (BI 907828) in advanced biliary tract cancer, pancreatic ductal adenocarcinoma or other solid tumors. Future Oncology 2024; 20(16) doi: 10.2217/fon-2023-0963
|
| 195 |
Victoria Spadafora, Benjamin R. Pryce, Alexander Oles, Erin E. Talbert, Martin Romeo, Silvia Vaena, Stefano Berto, Michael C. Ostrowski, David J. Wang, Denis C. Guttridge. Optimization of a mouse model of pancreatic cancer to simulate the human phenotypes of metastasis and cachexia. BMC Cancer 2024; 24(1) doi: 10.1186/s12885-024-12104-0
|
| 196 |
Silviu Stanciu, Florentina Ionita-Radu, Constantin Stefani, Daniela Miricescu, Iulia-Ioana Stanescu-Spinu, Maria Greabu, Alexandra Ripszky Totan, Mariana Jinga. Targeting PI3K/AKT/mTOR Signaling Pathway in Pancreatic Cancer: From Molecular to Clinical Aspects. International Journal of Molecular Sciences 2022; 23(17) doi: 10.3390/ijms231710132
|
| 197 |
Mohd Haris Jamal, MD Nasiruddin Khan. Developments in pancreatic cancer emerging therapies, diagnostic methods, and epidemiology. Pathology - Research and Practice 2025; 271 doi: 10.1016/j.prp.2025.156012
|
| 198 |
Christos Vallilas, Panagiotis Sarantis, Anastasios Kyriazoglou, Evangelos Koustas, Stamatios Theocharis, Athanasios G. Papavassiliou, Michalis V. Karamouzis. Gastrointestinal Stromal Tumors (GISTs): Novel Therapeutic Strategies with Immunotherapy and Small Molecules. International Journal of Molecular Sciences 2021; 22(2) doi: 10.3390/ijms22020493
|
| 199 |
Dixon J. Atkins, Jonah M. Rosas, Lisa K. Månsson, Nima Shahverdi, Siddharth S. Dey, Angela A. Pitenis. Survival-Associated Cellular Response Maintained in Pancreatic Ductal Adenocarcinoma (PDAC) Switched Between Soft and Stiff 3D Microgel Culture. ACS Biomaterials Science & Engineering 2024; 10(4) doi: 10.1021/acsbiomaterials.3c01079
|
| 200 |
Mohammad Alzoubi, Rahaf Al Jibarat, Ahmad Omar Saleh, Reem Eisa, Haneen Mosa Al-sha’ar, Tuqa M. Alfreijat, Juman Habboub, Rania Rashed, Rahaf Hanoun, Raghad Alkhateeb, Zaed Hamady. Clinicopathological differences and risk factors of early- versus late-onset pancreatic cancer: A systematic review and meta-analysis. iScience 2026; 29(9) doi: 10.1016/j.isci.2026.116643
|
| 201 |
Jiawei Fan, Ye Yu, Lanzhen Yan, Yuncang Yuan, Bin Sun, Dong Yang, Nan Liu, Jing Guo, Jie Zhang, Xudong Zhao. GAS6-based CAR-T cells exhibit potent antitumor activity against pancreatic cancer. Journal of Hematology & Oncology 2023; 16(1) doi: 10.1186/s13045-023-01467-9
|
| 202 |
Nikolett Kitti Dobos, Tamas Garay, Magdolna Herold, Alexandra Simon, Viktor Madar-Dank, Gyula Balka, Jozsef Gajdacsi, Magdolna Dank, Attila Marcell Szasz, Zoltan Herold. Immune Marker and C-Reactive Protein Dynamics and Their Prognostic Implications in Modulated Electro-Hyperthermia Treatment in Advanced Pancreatic Cancer: A Retrospective Analysis. Immuno 2024; 4(4) doi: 10.3390/immuno4040025
|
| 203 |
Hsuan‐Chen Liu, Daniel Davila Gonzalez, Dixita Ishani Viswanath, Robin Shae Vander Pol, Shani Zakiya Saunders, Nicola Di Trani, Yitian Xu, Junjun Zheng, Shu‐Hsia Chen, Corrine Ying Xuan Chua, Alessandro Grattoni. Sustained Intratumoral Administration of Agonist CD40 Antibody Overcomes Immunosuppressive Tumor Microenvironment in Pancreatic Cancer. Advanced Science 2023; 10(9) doi: 10.1002/advs.202206873
|
| 204 |
Wei Yen Chan, Hao-Wen Sim, Muhammad Abdi Haryono, Desmond Yip, Venessa Chin. Immune checkpoint inhibitors for advanced pancreatic cancer. Cochrane Database of Systematic Reviews 2023; 2023(2) doi: 10.1002/14651858.CD014523
|
| 205 |
Yukun Huang, Liang Chen, Yu Chen, Songlei Zhou, Xiaoying Xie, Jing Xie, Minghua Yu, Jun Chen. High-density lipoprotein-based nanoplatform reprograms tumor microenvironment and enhances chemotherapy against pancreatic ductal adenocarcinoma. Biomaterials 2025; 318 doi: 10.1016/j.biomaterials.2025.123147
|
| 206 |
Erika Stefàno, Gianluca Rovito, Luca G. Cossa, Federica De Castro, Viviana Vergaro, Asjad Ali, Giulia My, Danilo Migoni, Antonella Muscella, Santo Marsigliante, Michele Benedetti, Francesco Paolo Fanizzi, Massimiliano F. Peana. Novel Pt (II) Complexes With Anticancer Activity Against Pancreatic Ductal Adenocarcinoma Cells. Bioinorganic Chemistry and Applications 2024; 2024(1) doi: 10.1155/bca/5588491
|
| 207 |
Yijia Liu, Yanzhe Huang, Hongliang Luo, Xueqin Lin. The roles of Cryptochrome-1: the circadian clock as a control point in cancer therapy. Journal of Translational Medicine 2025; 23(1) doi: 10.1186/s12967-025-06702-0
|
| 208 |
Kenneth S. Ramos, Abeer A. I. Hassanin. Environmental Oncology. 2023; doi: 10.1007/978-3-031-33750-5_1
|
| 209 |
Renata Szydlak. Synergistic Inhibition of Pancreatic Cancer Cell Growth and Migration by Gemcitabine and Withaferin A. Biomolecules 2024; 14(9) doi: 10.3390/biom14091178
|
| 210 |
Tao Zhang, Yu Xiang, Hang Wang, Hong Yun, Yichun Liu, Xing Wang, Hao Zhang. Radiomics Combined with Multiple Machine Learning Algorithms in Differentiating Pancreatic Ductal Adenocarcinoma from Pancreatic Neuroendocrine Tumor: More Hands Produce a Stronger Flame. Journal of Clinical Medicine 2022; 11(22) doi: 10.3390/jcm11226789
|
| 211 |
Amber N. Habowski, Deepthi P. Budagavi, Sandra D. Scherer, Arin B. Aurora, Giuseppina Caligiuri, William F. Flynn, Ellen M. Langer, Jonathan R. Brody, Rosalie C. Sears, Giorgia Foggetti, Anna Arnal Estape, Don X. Nguyen, Katerina A. Politi, Xiling Shen, David S. Hsu, Donna M. Peehl, John Kurhanewicz, Renuka Sriram, Milagros Suarez, Sophie Xiao, Yuchen Du, Xiao-Nan Li, Nora M. Navone, Estefania Labanca, Christopher D. Willey. Patient-Derived Models of Cancer in the NCI PDMC Consortium: Selection, Pitfalls, and Practical Recommendations. Cancers 2024; 16(3) doi: 10.3390/cancers16030565
|
| 212 |
Bin Li, Michael S. Nelson, Omid Savari, Agnes G. Loeffler, Kevin W. Eliceiri. Differentiation of pancreatic ductal adenocarcinoma and chronic pancreatitis using graph neural networks on histopathology and collagen fiber features. Journal of Pathology Informatics 2022; 13 doi: 10.1016/j.jpi.2022.100158
|
| 213 |
Cristian Andres Carmona-Carmona, Elisa Dalla Pozza, Giulia Ambrosini, Andrea Errico, Ilaria Dando. Divergent Roles of Mitochondria Dynamics in Pancreatic Ductal Adenocarcinoma. Cancers 2022; 14(9) doi: 10.3390/cancers14092155
|
| 214 |
Sagnik Bhadury, Michele Peruzzi, Satwik Acharyya, Joel Eliason, Marina Pasca Di Magliano, Timothy L. Frankel, Visweswaran Ravikumar, Santhoshi Krishnan, Arvind Rao. Informed spatially aware patterns for multiplexed immunofluorescence data. Scientific Reports 2026; 16(1) doi: 10.1038/s41598-026-35341-8
|
| 215 |
Oliver Liang, Amy L. White, Timothy Fielder, Joo-Shik Shin, Sharon M. Sagnella, Ulf Schmitz, Dannel Yeo. High mesothelin expression is associated with low cytotoxic T cell infiltration in pancreatic cancer. Frontiers in Immunology 2025; 16 doi: 10.3389/fimmu.2025.1651687
|
| 216 |
Abdullah Khalid, Shamsher A. Pasha, Lyudmyla Demyan, Oliver Standring, Elliot Newman, Daniel A. King, Danielle DePeralta, Sepideh Gholami, Matthew J. Weiss, Marcovalerio Melis. Modified 5-Item Frailty Index (mFI-5) may predict postoperative outcomes after pancreatoduodenectomy for pancreatic Cancer. Langenbeck's Archives of Surgery 2024; 409(1) doi: 10.1007/s00423-024-03483-w
|
| 217 |
Ahmad Ali, Ugo Chianese, Chiara Papulino, Antonella Toraldo, Mawada Elmagboul Abdalla Abakar, Eugenia Passaro, Rosario Cennamo, Nunzio Del Gaudio, Lucia Altucci, Rosaria Benedetti. Metabolic Pathways as a Novel Landscape in Pancreatic Ductal Adenocarcinoma. Cancers 2022; 14(15) doi: 10.3390/cancers14153799
|
| 218 |
Francesca Ricciardiello, Laura Bergamaschi, Humberto De Vitto, Yang Gang, Taiping Zhang, Roberta Palorini, Ferdinando Chiaradonna. Suppression of the HBP Function Increases Pancreatic Cancer Cell Sensitivity to a Pan-RAS Inhibitor. Cells 2021; 10(2) doi: 10.3390/cells10020431
|
| 219 |
Zahra Shokati Eshkiki, Nasibeh Khayer, Atefeh Talebi, Reza Karbalaei, Abolfazl Akbari. Novel insight into pancreatic adenocarcinoma pathogenesis using liquid association analysis. BMC Medical Genomics 2022; 15(1) doi: 10.1186/s12920-022-01174-3
|
| 220 |
Caitlyn Smith, Wei Zheng, Jixin Dong, Yaohong Wang, Jinping Lai, Xiuli Liu, Feng Yin. Tumor microenvironment in pancreatic ductal adenocarcinoma: Implications in immunotherapy. World Journal of Gastroenterology 2022; 28(27): 3297-3313 doi: 10.3748/wjg.v28.i27.3297
|
| 221 |
Chaojie Huang, Ting Wang, Rui Chen, Yunyun Xu. Discovery of CMNPD31124 as a novel marine-derived PKMYT1 inhibitor for pancreatic ductal adenocarcinoma therapy: computational and biological insights. Frontiers in Pharmacology 2025; 16 doi: 10.3389/fphar.2025.1569765
|
| 222 |
Xin Chen, Herbert J. Zeh, Rui Kang, Guido Kroemer, Daolin Tang. Cell death in pancreatic cancer: from pathogenesis to therapy. Nature Reviews Gastroenterology & Hepatology 2021; 18(11) doi: 10.1038/s41575-021-00486-6
|
| 223 |
David Bauer, Lukas M. Carter, Mohamed I. Atmane, Roberto De Gregorio, Alexa Michel, Spencer Kaminsky, Sebastien Monette, Mengshi Li, Michael K. Schultz, Jason S. Lewis. 212Pb-Pretargeted Theranostics for Pancreatic Cancer. Journal of Nuclear Medicine 2024; 65(1) doi: 10.2967/jnumed.123.266388
|
| 224 |
Epiphane K. Silli, Mengfei Li, Yuting Shao, Yiran Zhang, Guilin Hou, Jiaqian Du, Jingdan Liang, Ying Wang. Liposomal nanostructures for Gemcitabine and Paclitaxel delivery in pancreatic cancer. European Journal of Pharmaceutics and Biopharmaceutics 2023; 192 doi: 10.1016/j.ejpb.2023.09.014
|
| 225 |
Monica E. Bonilla, Megan D. Radyk, Matthew D. Perricone, Ahmed M. Elhossiny, Alexis C. Harold, Paola I. Medina-Cabrera, Padma Kadiyala, Jiaqi Shi, Timothy L. Frankel, Eileen S. Carpenter, Michael D. Green, Cristina Mitrea, Costas A. Lyssiotis, Marina Pasca di Magliano. Metabolic landscape of the healthy pancreas and pancreatic tumor microenvironment. JCI Insight 2024; 9(18) doi: 10.1172/jci.insight.180114
|
| 226 |
Kimberly J. Jasmer, Kevin Muñoz Forti, Lucas T. Woods, Seunghee Cha, Gary A. Weisman. Therapeutic potential for P2Y2 receptor antagonism. Purinergic Signalling 2023; 19(2) doi: 10.1007/s11302-022-09900-3
|
| 227 |
Mathilde Resell, Elisabeth Pimpisa Graarud, Hanne-Line Rabben, Animesh Sharma, Lars Hagen, Linh Hoang, Nan T. Skogaker, Anne Aarvik, Magnus K. Svensson, Manoj Amrutkar, Caroline S. Verbeke, Surinder K. Batra, Gunnar Qvigstad, Timothy C. Wang, Anil Rustgi, Duan Chen, Chun-Mei Zhao. Knowledge Discovery in Databases of Proteomics by Systems Modeling in Translational Research on Pancreatic Cancer. Proteomes 2025; 13(2) doi: 10.3390/proteomes13020020
|
| 228 |
Chukwuebuka Ozoude, Connor Edvall, Shubhashri Ambhore, Narendra Kale, Yogaraj S Ramakrishnan, Rayat Hossain, Karl Van Horsen, Sakurako Tani, Yongki Choi, Venkatachalem Sathish, Sanku Mallik. Nanoparticles for Delivery of Encapsulated Drugs to Hypoxic Pancreatic Ductal Adenocarcinoma Cell Spheroids. Molecular Pharmaceutics 2026; 23(2) doi: 10.1021/acs.molpharmaceut.5c01395
|
| 229 |
Karthik Balakrishnan, Yi Xiao, Yuanhong Chen, Jixin Dong. Elevated Expression of Cell Adhesion, Metabolic, and Mucus Secretion Gene Clusters Associated with Tumorigenesis, Metastasis, and Poor Survival in Pancreatic Ductal Adenocarcinoma. Cancers 2024; 16(23) doi: 10.3390/cancers16234049
|
| 230 |
Ahmed Bendari, Oana Vele, Brett Baskovich, Alaa Bendari, Mona Sebika, Juan Luis Gomez Marti, Kritika Krishnamurthy, Saeed Asiry. Liquid Biopsy in Pancreatic Ductal Adenocarcinoma: Clinical Utility, Trials, and Future Directions. Gastroenterology Insights 2025; 16(4) doi: 10.3390/gastroent16040039
|
| 231 |
Gabrielle Wishart, Priyanka Gupta, Giuseppe Schettino, Andrew Nisbet, Eirini Velliou. 3d tissue models as tools for radiotherapy screening for pancreatic cancer. The British Journal of Radiology 2021; 94(1120) doi: 10.1259/bjr.20201397
|
| 232 |
|
| 233 |
Loran Nas, Boj Friedrich Hoppe, Anna Theresa Stüber, Sergio Grosu, Nicola Fink, Jan Rudolph, Sardi Hyska, Jens Ricke, Bastian Oliver Sabel. Enhancing pancreatic imaging in CT – prospective comparison of fixed versus individualized post-trigger delay in bolus tracking. European Journal of Radiology 2026; 203 doi: 10.1016/j.ejrad.2026.113048
|
| 234 |
Shuai Hao, Shuyi Xu, Liangzhu Li, Yaxian Li, Meiqi Zhao, Junsheng Chen, Shunying Zhu, Yueqing Xie, Hua Jiang, Jianwei Zhu, Mingyuan Wu. Tumour inhibitory activity on pancreatic cancer by bispecific nanobody targeting PD-L1 and CXCR4. BMC Cancer 2022; 22(1) doi: 10.1186/s12885-022-10165-7
|
| 235 |
Magali Perier, Litan Wang, Marine Simonneau, Jacqueline Ngo-Reymond, Julie Guillermet-Guibert, Maxime Lafond, Cyril Lafon. Formation and Characterization of Two Magnetic Three-Dimensional Spheroid Models of Murine Pancreatic Adenocarcinoma. Methods and Protocols 2025; 8(4) doi: 10.3390/mps8040075
|
| 236 |
. 2024; doi: 10.70675/3c759681z2a9bz424azadf8z7d3fe60d63aa
|
| 237 |
Manvi Rawat, Murari Kumar Jha, Pavan Kumar Agrawal, Arun Bhatt, Sumit Kumar Rai. Translational bioengineering perspectives on biosensors and nanorobotics for cancer theranostics. Discover Sensors 2026; 2(1) doi: 10.1007/s44397-026-00087-5
|
| 238 |
Luanluan Huang, Xiaoyan Chen, Ruiqi Liu, Ding Nan, Wenxuan Bao, Lixian Yang, Xiaomeng Dai, Jianming Tang, Haibo Zhang, Yanwei Lu. Targeting inflammasomes as an immunotherapeutic strategy for cancer. Journal of Translational Medicine 2025; 23(1) doi: 10.1186/s12967-025-06665-2
|
| 239 |
Oluwatosin A. Saibu, Temitope M. Ajayi, Damilola A. Omoboyowa, Oladapo O. Oladipo, Sodiq O. Hammed, Tope T. Odunitan, Adenrele T. Oluwafemi, Aderonke J. Adejuyigbe, Gideon O. Aloba, Toheeb A. Balogun, Abdullahi O.Alausa, Damilola S. Bodun. Molecular mechanics and dynamics simulation of CD-47/SIRPα blockade study: A computational study on overcoming immunotherapeutic resistance in pancreatic ductal adenocarcinoma. Arabian Journal of Chemistry 2023; 16(11) doi: 10.1016/j.arabjc.2023.105265
|
| 240 |
Antonella Argentiero, Alessandro Andriano, Ingrid Catalina Caradonna, Giulia de Martino, Vanessa Desantis. Decoding the Intricate Landscape of Pancreatic Cancer: Insights into Tumor Biology, Microenvironment, and Therapeutic Interventions. Cancers 2024; 16(13) doi: 10.3390/cancers16132438
|
| 241 |
Wei Zhang, Yanwen Xu, Rongjun Guo, Peiling Zhuang, Huixia Hong, Hui Tan, Mingfeng Wang. Theranostic Bottle-Brush Polymers Tailored for Universal Solid-Tumor Targeting. ACS Nano 2024; 18(18) doi: 10.1021/acsnano.3c11755
|
| 242 |
Cameron J. Herting, Gregory B. Lesinski. Immune Strategies for Gastrointestinal Cancer. Cancer Immunotherapy 2021; 2 doi: 10.1007/13905_2021_1
|
| 243 |
S. N. Gancedo, A. Sahores, N. Gómez, N. Di Siervi, M. May, A. Yaneff, M. G. de Sousa Serro, N. Fraunhoffer, N. Dusetti, J. Iovanna, C. Shayo, C. A. Davio, B. González. The xenobiotic transporter ABCC4/MRP4 promotes epithelial mesenchymal transition in pancreatic cancer. Frontiers in Pharmacology 2024; 15 doi: 10.3389/fphar.2024.1432851
|
| 244 |
Zeliang Zhang, Ying Tian, Bo Zhang, Kexiang Zhu. Metabolic reprogramming in pancreatic cancer: interplay of glucose, lipid, and amino acid metabolism in tumor progression. Cytotechnology 2026; 78(5) doi: 10.1007/s10616-026-01052-1
|
| 245 |
Jihoon Ko, Sujin Hyung, Sunghun Cheong, Yoojin Chung, Noo Li Jeon. Revealing the clinical potential of high-resolution organoids. Advanced Drug Delivery Reviews 2024; 207 doi: 10.1016/j.addr.2024.115202
|
| 246 |
Evangelos Koustas, Panagiotis Sarantis, Athanasios G. Papavassiliou, Michalis V. Karamouzis. The Resistance Mechanisms of Checkpoint Inhibitors in Solid Tumors. Biomolecules 2020; 10(5) doi: 10.3390/biom10050666
|
| 247 |
Katelin Magnan, Linford Williams, Qian Wang, Julia Meade. A Nine-Year-Old Child With Metastatic Pancreatic Adenocarcinoma. Cureus 2024; doi: 10.7759/cureus.60670
|
| 248 |
Ying Xing, Gangqiang Shi, Zhengli Li, Xiancheng Liu, Linghu Nie, Yu Zhang, Yiqin Song, Shilin Sun, Mike K. S. Chan, Michelle B. F. Wong, Krista Casazza, Jonathan R. T. Lakey, Yuping Chen, Xuekai Zhu, Yunfeng Feng. VHH-based CAR-T cells targeting Claudin 18.2 show high efficacy in pancreatic cancer models. Frontiers in Immunology 2026; 16 doi: 10.3389/fimmu.2025.1638585
|
| 249 |
Chenyan Zhang, Ruizhen Li, Jun Ji, Xiaofen Li, Dan Cao. Impact of adding recurrence/metastasis-directed therapy to systemic therapy in postoperative recurrent or metastatic pancreatic adenocarcinoma: a retrospective cohort study. Therapeutic Advances in Medical Oncology 2026; 18 doi: 10.1177/17588359261417639
|
| 250 |
Giada Mondanelli, Martina Mandarano, Maria Laura Belladonna, Chiara Suvieri, Cristina Pelliccia, Guido Bellezza, Angelo Sidoni, Agostinho Carvalho, Ursula Grohmann, Claudia Volpi. Current Challenges for IDO2 as Target in Cancer Immunotherapy. Frontiers in Immunology 2021; 12 doi: 10.3389/fimmu.2021.679953
|
| 251 |
Andrés Gordo-Ortiz, Inés Ortiz-de-Solórzano, Flor Navarro. Cytokine-based immunotherapy - Part B. International Review of Cell and Molecular Biology 2026; 401 doi: 10.1016/bs.ircmb.2025.03.001
|
| 252 |
Yang Iris. Targeted delivery of therapeutic oligonucleotides in pancreatic cancer. Journal of Biology and Medicine 2022; 6(1) doi: 10.17352/jbm.000028
|
| 253 |
Sangyeop Hyun, Daechan Park. Challenges in genomic analysis of model systems and primary tumors of pancreatic ductal adenocarcinoma. Computational and Structural Biotechnology Journal 2022; 20 doi: 10.1016/j.csbj.2022.08.064
|
| 254 |
Chris T.P. Do, Prabhakar Pitta Venkata, Jack Y. Prochnau, Deepika Singh, Santosh Timilsina, Panneerdoss Subbarayalu, Daisy Medina, Shahad Abdulsahib, Saif Nirzhor, Sajid Khan, Guiming Li, Srikanth R. Polusani, Daohong Zhou, Pei Wang, Yidong Chen, Ratna K. Vadlamudi, Matthew J. Hart, Radhika Amaradhi, Stanton F. McHardy, Manjeet K. Rao. Targeting DDR2 for Treating Pancreatic Cancer. Molecular Cancer Therapeutics 2025; 24(10) doi: 10.1158/1535-7163.MCT-24-1226
|
| 255 |
Fionnuala Crowley, Wungki Park, Eileen M. O’Reilly. Targeting DNA damage repair pathways in pancreas cancer. Cancer and Metastasis Reviews 2021; 40(3) doi: 10.1007/s10555-021-09983-1
|
| 256 |
Sena Şen, Merve Çiğdem Özgel, Şeref Buğra Tunçer, Hamza Uğur Bozbey, Senem Karabulut, Didem Taştekin. A Pilot Study of Exploring miRNA–Protein Interaction Networks in Pancreatic Ductal Adenocarcinoma Patients: Implications for Diagnosis and Prognosis. Diagnostics 2025; 15(19) doi: 10.3390/diagnostics15192479
|
| 257 |
Vinod Ganju, Gavin Marx, Scott Pattison, Nancy B. Amaro-Mugridge, Jing-Ting Zhao, Bryan R.G. Williams, Jennifer A. MacDiarmid, Himanshu Brahmbhatt. Phase I/IIa Trial in Advanced Pancreatic Ductal Adenocarcinoma Treated with Cytotoxic Drug-Packaged, EGFR-Targeted Nanocells and Glycolipid-Packaged Nanocells. Clinical Cancer Research 2024; 30(2) doi: 10.1158/1078-0432.CCR-23-1821
|
| 258 |
Marco Huberts, Elham Aida Farshadi, Farzana Mohammad, Jie Ju, Andrew Stubbs, Ron A.M. Fouchier, Bernadette G. van den Hoogen. Identifying gene expression signatures of oncolytic virus response in patient-derived pancreatic ductal adenocarcinoma organoids. Molecular Therapy Oncology 2025; 33(4) doi: 10.1016/j.omton.2025.201064
|
| 259 |
Sakshi Bai, Jahnavi Ethakota, Fnu Payal, Oboseh John Ogedegebe, Akshay Kumar, Olanipekun Lanny Ntukidem, Fnu Sagar, Bipneet Singh, Akhil Rahman. Pancreatic Adenocarcinoma and Brain Mets: Literature Review. Case Reports in Clinical Medicine 2025; 14(06) doi: 10.4236/crcm.2025.146039
|
| 260 |
Catarina Pimpão, Diogo M. Engrácia, Graça Soveral, Filipa Mendes. Aquaporin‐3 and aquaporin‐5 impact the development of pancreatic ductal adenocarcinoma spheroids. FEBS Open Bio 2026; doi: 10.1002/2211-5463.70270
|
| 261 |
Shintaro Fumoto, Tsuyoshi Yamamoto, Kazuya Okami, Yuina Maemura, Chisato Terada, Asako Yamayoshi, Koyo Nishida. Understanding In Vivo Fate of Nucleic Acid and Gene Medicines for the Rational Design of Drugs. Pharmaceutics 2021; 13(2) doi: 10.3390/pharmaceutics13020159
|
| 262 |
Mengyang Ding, Jingyu Liu, Honghui Lv, Yanlin Zhu, Yumiao Chen, Hui Peng, Sairong Fan, Xiaoming Chen. Knocking down GALNT6 promotes pyroptosis of pancreatic ductal adenocarcinoma cells through NF-κB/NLRP3/GSDMD and GSDME signaling pathway. Frontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1097772
|
| 263 |
Bassel F. El-Rayes, Mehmet Akce. Immunotherapy in Pancreatic Cancer. Digestive Disease Interventions 2020; 4(04) doi: 10.1055/s-0040-1718904
|
| 264 |
Anna M. Kolarzyk, Yujin Kwon, Elizabeth Oh, Keng-Jung Lee, Su-Yeon Cho, Issahy Cano, Renhao Lu, Tae Joon Kwak, Jaehyun Lee, Gigi Wong, Andrew H. Kim, Omar Gandarilla, Manuel Hidalgo, Won Kyu Kim, Esak Lee. Non-canonical ALK7 pathways promote pancreatic cancer metastasis through β-catenin/MMP-mediated basement membrane breakdown and intravasation. Molecular Cancer 2025; 24(1) doi: 10.1186/s12943-025-02384-w
|
| 265 |
Tejinder Kaur, Debasis Nayak, Arnav Joshi, Junan Li, Amy Hite, Rajgopal Govindarajan. Loss of Regulator of G Protein Signaling 11 Promotes Protumorigenic Features in Pancreatic Cancer. Molecular Cancer Research 2026; 24(1) doi: 10.1158/1541-7786.MCR-25-0144
|
| 266 |
Shunsuke Imamura, Takeshi Uehara, Mai Iwaya, Shiho Asaka, Shinsuke Sugenoya, Hiroshi Sawaguchi, Yasuhiro Kuraishi, Tomoyuki Nakajima, Shotaro Komamura, Akira Nakamura, Takefumi Kimura, Yugo Iwaya, Akira Shimizu, Yuji Soejima, Hiroyoshi Ota, Tadanobu Nagaya. Immunohistochemical analysis and scRNA-Seq identifies vascular endothelial CXCR4 expression as a predictor of poor prognosis in pancreatic ductal adenocarcinoma. Translational Oncology 2026; 71 doi: 10.1016/j.tranon.2026.102916
|
| 267 |
Shiyu Liu, Fan Li, Li Deng, Qiongqiong Ma, Wenyi Lu, Zhuoqian Zhao, Huanzhen Liu, Yixuan Zhou, Manli Hu, Hui Wang, Yingbin Yan, Mingfeng Zhao, Hongkai Zhang, Mingjuan Du. Claudin18.2 bispecific T cell engager armed oncolytic virus enhances antitumor effects against pancreatic cancer. Molecular Therapy - Oncolytics 2023; 30 doi: 10.1016/j.omto.2023.08.011
|
| 268 |
Prasanna Srinivasan Ramalingam, Md Sadique Hussain, Gayathri Chellasamy, Sujatha Elangovan, Divya Sharma, Premkumar T, Rudra Awdhesh Kumar Mishra, Gothandam Kodiveri Muthukaliannan, Tajamul Hussain, Salman Alrokayan, Purushothaman Balakrishnan, Janaki Ramaiah Mekala, Sivakumar Arumugam. Repurposing DPP-4 inhibitors as anticancer agents in KRAS-mutated pancreatic ductal adenocarcinoma. BMC Pharmacology and Toxicology 2025; 26(1) doi: 10.1186/s40360-025-01020-z
|
| 269 |
Karinna Georgiana Pele, Alejandro Calderón-Villalba, Hippolyte Amaveda, Mario Mora, Jack Zhang-Zhou, María Ángeles Pérez, José Manuel García-Aznar, Pilar Alamán-Díez, Elena García-Gareta. Novel hydrogel-based cancer-on-a-chip models for growth of 3D multi-cellular structures and investigation of early angiogenesis in pancreatic ductal adenocarcinoma. Colloids and Surfaces B: Biointerfaces 2025; 253 doi: 10.1016/j.colsurfb.2025.114736
|
| 270 |
Jae Min Lee, Moon Sup Yoon, Min Jeong Jo, Su Jeong Kang, Sunghyun Bong, Chae Eun Jin, Ji-hyun Park, Hwan Ma, Kyu Ha Lee, Yoon Seok Roh, Chan-Su Park, Chun-Woong Park, Dae Hwan Shin. Sequential gemcitabine and panobinostat-loaded albumin nanoparticle delivery via thermosensitive hydrogel in pancreatic peritoneal metastasis. Journal of Controlled Release 2026; 395 doi: 10.1016/j.jconrel.2026.115029
|
| 271 |
Stefania Moz, Nicole Contran, Monica Facco, Valentina Trimarco, Mario Plebani, Daniela Basso. Vitamin D Prevents Pancreatic Cancer-Induced Apoptosis Signaling of Inflammatory Cells. Biomolecules 2020; 10(7) doi: 10.3390/biom10071055
|
| 272 |
Shubham Mehta, Iti Patel, Gautam Patel. Advances in pyrimidine-like heterocyclic scaffolds: Innovative synthetic method for malic enzyme inhibition in pancreatic ductal adenocarcinoma (PDAC) - A comprehensive review. European Journal of Medicinal Chemistry 2026; 307 doi: 10.1016/j.ejmech.2026.118657
|
| 273 |
Gianluca Rovito, Erika Stefàno, Asjad Ali, Danilo Migoni, Federica De Castro, Antonella Muscella, Francesco Paolo Fanizzi, Michele Benedetti, Santo Marsigliante. Evaluation of the Cytotoxic and Antimigratory Activity Induced by [Pt(1-hexyl-1H-imidazole)(η1-C2H4OEt)(phen)]Cl in Pancreatic Ductal Adenocarcinoma Cells. International Journal of Molecular Sciences 2026; 27(14) doi: 10.3390/ijms27146315
|
| 274 |
Anni Lepland, Kadi-Liis Veiman. Cancer-Targeted Drug Delivery. Methods in Pharmacology and Toxicology 2025; doi: 10.1007/978-1-0716-4374-7_6
|
| 275 |
Vahid Khalaj, Alyssa M. Waller, MacKenzie V. Demmel, Urvinder Kaur Sardarni, Jack T. Adams, Aidan Collier, Ana Maria Zaske, Majid Momeny, Jennifer M. Bailey-Lundberg, Ali Azhdarinia. ADA2-Functionalized OMVs Remodel the Tumor Microenvironment in Pancreatic Cancer. Pharmaceutics 2026; 18(8) doi: 10.3390/pharmaceutics18080920
|
| 276 |
Marco Carofiglio, Marzia Conte, Luisa Racca, Valentina Cauda. Synergistic Phenomena between Iron-Doped ZnO Nanoparticles and Shock Waves Exploited against Pancreatic Cancer Cells. ACS Applied Nano Materials 2022; 5(11) doi: 10.1021/acsanm.2c04211
|
| 277 |
Jae Hyun Byun, Paul F. Lebeau, Jackie Trink, Nikhil Uppal, Matthew B. Lanktree, Joan C. Krepinsky, Richard C. Austin. Endoplasmic reticulum stress as a driver and therapeutic target for kidney disease. Nature Reviews Nephrology 2025; 21(5) doi: 10.1038/s41581-025-00938-1
|
| 278 |
Manali Rupareliya, Pravin Shende. . Advances in Experimental Medicine and Biology 2024; doi: 10.1007/5584_2024_820
|
| 279 |
Sara Maher, Hesham A. Elmeligy, Tarek Aboushousha, Noha Said Helal, Yousra Ossama, Mahmoud Rady, Ahmed Mohamed A. Hassan, Manal Kamel. Synergistic immunomodulatory effect of synbiotics pre- and postoperative resection of pancreatic ductal adenocarcinoma: a randomized controlled study. Cancer Immunology, Immunotherapy 2024; 73(6) doi: 10.1007/s00262-024-03686-6
|
| 280 |
Janina Werner, Patrick Bernhard, Miguel Cosenza-Contreras, Niko Pinter, Matthias Fahrner, Prama Pallavi, Johannes Eberhard, Peter Bronsert, Felix Rückert, Oliver Schilling. Targeted and explorative profiling of kallikrein proteases and global proteome biology of pancreatic ductal adenocarcinoma, chronic pancreatitis, and normal pancreas highlights disease-specific proteome remodelling. Neoplasia 2023; 36 doi: 10.1016/j.neo.2022.100871
|
| 281 |
Konstantin M. P. Wolf, Lea S. Ottenwald, Martin Wartenberg, Mamta Chabria, Viola Vogel. Targeting cancer matrix mechanics: fibronectin fiber relaxation correlates with ADAM8 expression in PDAC and is amenable to in vitro modulation. Frontiers in Biophysics 2026; 4 doi: 10.3389/frbis.2026.1781425
|
| 282 |
Gelu Mihai Breaza, Florin Emil Hut, Octavian Cretu, Simona-Alina Abu-Awwad, Ahmed Abu-Awwad, Laurențiu Vasile Sima, Radu Gheorghe Dan, Cristina Ana-Maria Dan, Raluca Maria Closca, Flavia Zara. Correlation Between Systemic Inflammation, Gut Microbiome Dysbiosis and Postoperative Complications After the Modified Whipple Procedure. Biomedicines 2025; 13(1) doi: 10.3390/biomedicines13010104
|
| 283 |
Sara S. Cotes, Valeria I. Rodríguez, Vanessa A. Narváez, Esteban A. Rodríguez-Meléndez, Irene Morales, Katja Meyer, Sara Leal-Marín, Alex A. Lopera, Claudia M. Arenas-Gómez, Carlos A. Orozco, Diego A. Garzón-Alvarado, Juan J. Vaca-González. Physicochemical Characterization of Magnetically Responsive Fe3O4@SiO2@HAGel Nanoplatforms for Controlled Gemcitabine Delivery. Journal of Inorganic and Organometallic Polymers and Materials 2026; doi: 10.1007/s10904-026-04207-x
|
| 284 |
Nneka E. Mbah, Damien Sutton, Hanna S. Hong, Rashi Singhal, Rosa E. Menjivar, Matthew D. Perricone, Heather Giza, Peter Sajjakulnukit, Amy L. Myers, Zeribe C. Nwosu, Jonathan M. Alektiar, Jason Lin, Daniel Long, Anthony C. Andren, Li Zhang, Howard C. Crawford, Timothy L. Frankel, Marina Pasca di Magliano, Luigi Franchi, Yatrik M. Shah, Costas A. Lyssiotis. Tumor cell death by ferroptosis contributes to an immunosuppressive tumor microenvironment in syngeneic murine models of cancer. Cancer & Metabolism 2026; 14(1) doi: 10.1186/s40170-026-00428-3
|
| 285 |
Mariana Esteves, Ana Miguel Matos, Maria Teresa Cruz. Oncolytic viruses: A novel therapeutic approach for pancreatic cancer. Molecular Therapy Oncology 2025; 33(4) doi: 10.1016/j.omton.2025.201069
|
| 286 |
Gaurav Sheth, Shailesh R. Shah, Prabal Sengupta, Tushar Jarag, Sabbirhusen Chimanwala, Kalapatapu V. V. M. Sairam, Vaibhav Jain, Rashmi Talwar, Avinash Dhanave, Mehul Raviya, Soumya Menon, Shivangi Trivedi, Trinadha Rao Chitturi. In the Quest for Potent and Selective Malic Enzyme 3 Inhibitors for the Treatment of Pancreatic Ductal Adenocarcinoma. ACS Medicinal Chemistry Letters 2023; 14(1) doi: 10.1021/acsmedchemlett.2c00369
|
| 287 |
Qi Wang, Berina Šabanović, Azhar Awada, Chiara Reina, Alexandra Aicher, Jiajia Tang, Christopher Heeschen. Single-cell omics: a new perspective for early detection of pancreatic cancer?. European Journal of Cancer 2023; 190 doi: 10.1016/j.ejca.2023.112940
|
| 288 |
Zan Hu, Jie Meng. Recent Advances and Evolving Strategies of Photothermal Immunotherapy in Pancreatic Cancer Treatment. MedComm – Biomaterials and Applications 2025; 4(4) doi: 10.1002/mba2.70034
|
| 289 |
. 2024; doi: 10.70675/82f75518z24b6z4e99zbddbz8f97eac7d024
|
| 290 |
Transcriptomic analysis of laser-capture microdissected tumors reveals RAD51AP1 as a tumor-specific marker associated progression from pancreatic intraepithelial neoplasia to invasive pancreatic cancer. Cancer Cell International 2025; 25(1) doi: 10.1186/s12935-025-03810-1
|
| 291 |
Kenta Shinzawa, Daiki Kageta, Robert J. Nash, George W.J. Fleet, Tatsushi Imahori, Atsushi Kato. Azobenzene derivatives show anti-cancer activity against pancreatic cancer cells only under nutrient starvation conditions via G0/G1 cell cycle arrest. Tetrahedron 2021; 85 doi: 10.1016/j.tet.2021.132077
|
| 292 |
Manjul Rana, Rita Kansal, Mehdi Chaib, Bin Teng, Michelle Morrrison, David Neil Hayes, Ansley G. Stanfill, David Shibata, James A. Carson, Liza Makowski, Evan S. Glazer. The pancreatic cancer immune tumor microenvironment is negatively remodeled by gemcitabine while TGF‐β receptor plus dual checkpoint inhibition maintains antitumor immune cells. Molecular Carcinogenesis 2022; 61(6) doi: 10.1002/mc.23401
|
| 293 |
Zhi-gang Zhu, Lei Chen, Dong-liu Miao, Yiqi Jin, Qiong Wu. Integrated analysis of senescence-associated genes in pancreatic ductal adenocarcinoma. Frontiers in Genetics 2022; 13 doi: 10.3389/fgene.2022.941389
|
| 294 |
Mariana Souto, Tiago Cúrdia Gonçalves, José Cotter. Obesity and Pancreatic Diseases: From Inflammation to Oncogenesis and the Impact of Weight Loss Interventions. Nutrients 2025; 17(14) doi: 10.3390/nu17142310
|
| 295 |
Ana Beatriz Dias, Anna Ohradanova-Repic, Alma Dupanovic, Patrick Fischer, Filip Horvat, Lisa-Marie Appel, Niccolò Bragato, Laura Gebetsberger, Sandra Barna, Joachim Widder, Dietmar Georg, Sylvia Kerschbaum-Gruber, Dea Slade. ATR inhibition sensitizes pancreatic cancer cells to cytotoxic and immunogenic effects of X-ray and carbon ion irradiation. Radiotherapy and Oncology 2026; 222 doi: 10.1016/j.radonc.2026.111699
|
| 296 |
Lakshmi Sai Pratyusha Bugata, Deepanshi Dhar, Rama Kant, Robin Kumar, Md. Imtiazul Kabir, Chapla Agarwal, Rajesh Agarwal, Komal Raina. Chemopreventive Effect of Bitter Melon (Momordica charantia) Juice on Pancreatic Carcinogenesis in LSL‐KrasG12D/+; p48Cre/+ Mice. Molecular Carcinogenesis 2026; doi: 10.1002/mc.70164
|
| 297 |
Jack Chen, Edward G. Lynn, Tamana R. Yousof, Hitesh Sharma, Melissa E. MacDonald, Jae Hyun Byun, Bobby Shayegan, Richard C. Austin. Scratching the Surface—An Overview of the Roles of Cell Surface GRP78 in Cancer. Biomedicines 2022; 10(5) doi: 10.3390/biomedicines10051098
|
| 298 |
Elena García-Gareta, Alejandro Calderón-Villalba, Pilar Alamán-Díez, Carlos Gracia Costa, Pedro Enrique Guerrero, Carlota Mur, Ana Rueda Flores, Nerea Olivera Jurjo, Patricia Sancho, María Ángeles Pérez, José Manuel García-Aznar. Physico-chemical characterization of the tumour microenvironment of pancreatic ductal adenocarcinoma. European Journal of Cell Biology 2024; 103(2) doi: 10.1016/j.ejcb.2024.151396
|
| 299 |
Debamitra Chakraborty, Bradley N. Mills, Jing Cheng, Ivan Komissarov, Scott A. Gerber, Roman Sobolewski. Development of Terahertz Imaging Markers for Pancreatic Ductal Adenocarcinoma using Maximum A Posteriori Probability (MAP) Estimation. ACS Omega 2023; 8(11) doi: 10.1021/acsomega.2c07080
|
| 300 |
Mukti Vats, Drishti Rathod, Henis Patel, Terjahna Richards, Ketan Patel. Self-emulsifying nano-PND oral delivery systems of PND1186: In silico modeling for bioavailability estimation. Journal of Molecular Liquids 2025; 426 doi: 10.1016/j.molliq.2025.127161
|
| 301 |
Claudia Vilardo, Annalisa Di Domenico, Donatella Delle Cave. Special Issue “Molecular Mechanisms and Therapies of Pancreatic Cancer: 2nd Edition”. International Journal of Molecular Sciences 2026; 27(19) doi: 10.3390/ijms27198735
|
| 302 |
Valentina Giansante, Gianmarco Stati, Silvia Sancilio, Emanuela Guerra, Saverio Alberti, Roberta Di Pietro. The Dual Role of Necroptosis in Pancreatic Ductal Adenocarcinoma. International Journal of Molecular Sciences 2023; 24(16) doi: 10.3390/ijms241612633
|
| 303 |
Boshra Yosef, Viktória Venglovecz. TRPV6-Mediated Ca2+ Signaling in Pancreatic Ductal Adenocarcinoma: From Cellular Physiology to Therapeutic Opportunities. Cancers 2026; 18(10) doi: 10.3390/cancers18101670
|
| 304 |
Pancreatic Cancer: Basic Mechanisms and Therapies. Advances in Cancer Research 2023; 159 doi: 10.1016/bs.acr.2023.02.005
|
| 305 |
Zerui Lu, Wenxin Zhu, Xinjian Liu. Application prospects of tumor vaccines for pancreatic cancer: From TAAs to TSAs and combination strategies. Seminars in Oncology 2025; 52(5) doi: 10.1016/j.seminoncol.2025.152399
|
| 306 |
Immacolata Maietta, África González-Fernández, Rosana Simón-Vázquez. Harnessing epigenetic inhibitors: A promising approach for overcoming challenges in pancreatic ductal adenocarcinoma treatment. Advanced Drug Delivery Reviews 2025; 224 doi: 10.1016/j.addr.2025.115638
|
| 307 |
Yongji Zeng, Ling Yin, Jiuli Zhou, Renya Zeng, Yi Xiao, Adrian R. Black, Tuo Hu, Pankaj K. Singh, Feng Yin, Surinder K. Batra, Fang Yu, Yuanhong Chen, Jixin Dong. MARK2 regulates chemotherapeutic responses through class IIa HDAC-YAP axis in pancreatic cancer. Oncogene 2022; 41(31) doi: 10.1038/s41388-022-02399-3
|
| 308 |
Prasanna Srinivasan Ramalingam, Muhammad Afzal, M. Arockia Babu, Rekha M. M., Samir Sahoo, Surya Nath Pandey, Haider Ali, Md Sadique Hussain, Gaurav Gupta, Janaki Ramaiah Mekala, Sivakumar Arumugam. Targeting cancer via macrophage-derived exosomal miRNAs: implications for tumor progression and resistance. Frontiers in Immunology 2025; 16 doi: 10.3389/fimmu.2025.1683799
|
| 309 |
J. Rodon Ahnert, D.S.-W. Tan, I. Garrido-Laguna, W. Harb, A. Bessudo, J.T. Beck, S. Rottey, N. Bahary, N. Kotecki, Z. Zhu, S. Deng, K. Kowalski, C. Wei, N. Pathan, R.J. Laliberte, W.A. Messersmith. Avelumab or talazoparib in combination with binimetinib in metastatic pancreatic ductal adenocarcinoma: dose-finding results from phase Ib of the JAVELIN PARP MEKi trial. ESMO Open 2023; 8(4) doi: 10.1016/j.esmoop.2023.101584
|
| 310 |
Helen B. Binang, Chamini J. Perera, Minoti V. Apte. Role of Pancreatic Tumour-Derived Exosomes and Their Cargo in Pancreatic Cancer-Related Diabetes. International Journal of Molecular Sciences 2023; 24(12) doi: 10.3390/ijms241210203
|
| 311 |
Wenting Zhu, Hang Yu, Menglei Jia, Caiyan Lin, Zhongwen Yuan, Xiaoxiao Tan, Pengke Yan. Multi-targeting liposomal codelivery of cisplatin and rapamycin inhibits pancreatic cancer growth and metastasis through stromal modulation. International Journal of Pharmaceutics 2023; 644 doi: 10.1016/j.ijpharm.2023.123316
|
| 312 |
Mahmoud Yousef, Mark W Hurd, Abdelrahman Yousef, Ethan B Ludmir, Ashwathy B Pillai, Jennifer Peterson, Eugene J Koay, Sali Albarouki, Ching-Wei Tzeng, Rebecca Snyder, Matthew H G Katz, Huamin Wang, Michael J Overman, Anirban Maitra, Shubham Pant, Brandon G Smaglo, Robert A Wolff, James Yao, John P Shen, Dan Zhao. Clinical and molecular characteristics of patients with brain metastasis secondary to pancreatic ductal adenocarcinoma. The Oncologist 2025; 30(1) doi: 10.1093/oncolo/oyae182
|
| 313 |
Parinishtha Bhalla, David Dueñas Gaviria, Patrick Kupczyk, Ali Seif Amir Hosseini, Lena Conradi, Uli Fehrenbach, Matthaeus Felsenstein, Dou Ma, Alexander Semaan, Shadi Albarqouni. Federated CT foundation models for multi-center detection of lymph node metastasis in pancreatic cancer. Scientific Reports 2026; 16(1) doi: 10.1038/s41598-026-47631-2
|
| 314 |
Degao Huang, Heyang Zhang, Yu Zhang, Congliang Chen, Kexin Lin, Xia Wang, Peipei Wang. Role of Aldo-Keto reductase family 1 member C in cancer progression: a special focus on the role of AKR1C1 in pancreatic cancer. Medical Oncology 2025; 43(2) doi: 10.1007/s12032-025-03234-x
|
| 315 |
Khandoker Usran Ferdous, Mulu Z. Tesfay, Aleksandra Cios, Randal S. Shelton, Conner Hartupee, Alicja Urbaniak, Jean Christopher Chamcheu, Michail N. Mavros, Emmanouil Giorgakis, Bahaa Mustafa, Camila C. Simoes, Isabelle R. Miousse, Alexei G. Basnakian, Omeed Moaven, Steven R. Post, Martin J. Cannon, Thomas Kelly, Bolni Marius Nagalo. Enhancing Neoadjuvant Virotherapy’s Effectiveness by Targeting Stroma to Improve Resectability in Pancreatic Cancer. Biomedicines 2024; 12(7) doi: 10.3390/biomedicines12071596
|
| 316 |
Raviteja Bulusu. Enhanced anticancer activity of novel pyrimidine nucleoside analog in pancreatic cancer. American Journal of Cancer Research 2025; 15(8) doi: 10.62347/ARCZ1924
|
| 317 |
Raphaël Peiffer, Emilie Laverdeur, Anthoula Gaigneaux, Yasmine Boumahd, Charlotte Gullo, Gilles Rademaker, Rebekah Crake, Arnaud Lavergne, Naïma Maloujahmoum, Ferman Agirman, Michael Herfs, Atsushi Masamune, Elisabeth Letellier, Akeila Bellahcène, Olivier Peulen. Targeting myoferlin in ER/Golgi vesicle trafficking reprograms pancreatic cancer-associated fibroblasts. The EMBO Journal 2025; 44(22) doi: 10.1038/s44318-025-00570-6
|
| 318 |
Selas T. F. Bots, Tom J. Harryvan, Christianne Groeneveldt, Priscilla Kinderman, Vera Kemp, Nadine van Montfoort, Rob C. Hoeben. Preclinical evaluation of the gorilla‐derived HAdV‐B AdV‐lumc007 oncolytic adenovirus ‘GoraVir’ for the treatment of pancreatic ductal adenocarcinoma. Molecular Oncology 2024; 18(5) doi: 10.1002/1878-0261.13561
|
| 319 |
Linhan Ye, Zongyao Chen, Jingcheng Zhang, Qiaolin Li. Modeling the Transitional Phase of Epithelial Cells Reveals Prognostic and Therapeutic Targets in Pancreatic Ductal Adenocarcinoma. Cancers 2025; 17(11) doi: 10.3390/cancers17111813
|
| 320 |
Abdulaziz Alhussan, Nolan Jackson, Sarah Eaton, Nancy Dos Santos, Ingrid Barta, Josh Zaifman, Sam Chen, Yuen Yi C. Tam, Sunil Krishnan, Devika B. Chithrani. Lipid-Nanoparticle-Mediated Delivery of Docetaxel Prodrug for Exploiting Full Potential of Gold Nanoparticles in the Treatment of Pancreatic Cancer. Cancers 2022; 14(24) doi: 10.3390/cancers14246137
|
| 321 |
Vanessa F. Bonazzi, Lauren G. Aoude, Sandra Brosda, Julia J. Bradford, James M. Lonie, Kelly A. Loffler, Michael G. Gartside, Kalpana Patel, Pamela Mukhopadhyay, Colm Keane, Val Gebski, James G. Kench, David Goldstein, Nicola Waddell, Andrew P. Barbour. C‐reactive protein is a prognostic biomarker in pancreatic ductal adenocarcinoma patients. Asia-Pacific Journal of Clinical Oncology 2025; 21(1) doi: 10.1111/ajco.13993
|
| 322 |
Katelyn L. Donahue, Hannah R. Watkoske, Padma Kadiyala, Wenting Du, Kristee Brown, Michael K. Scales, Ahmed M. Elhossiny, Carlos E. Espinoza, Emily L. Lasse Opsahl, Brian D. Griffith, Yukang Wen, Lei Sun, Ashley Velez-Delgado, Nur M. Renollet, Jacqueline Morales, Nicholas M. Nedzesky, Rachael K. Baliira, Rosa E. Menjivar, Paola I. Medina-Cabrera, Arvind Rao, Benjamin Allen, Jiaqi Shi, Timothy L. Frankel, Eileen S. Carpenter, Filip Bednar, Yaqing Zhang, Marina Pasca di Magliano. Oncogenic KRAS-Dependent Stromal Interleukin-33 Directs the Pancreatic Microenvironment to Promote Tumor Growth. Cancer Discovery 2024; 14(10) doi: 10.1158/2159-8290.CD-24-0100
|
| 323 |
Felice Giuliante, Elena Panettieri, Andrea Campisi, Alessandro Coppola, Maria Vellone, Agostino M. De Rose, Francesco Ardito. Treatment of oligo-metastatic pancreatic ductal adenocarcinoma to the liver: is there a role for surgery? A narrative review. International Journal of Surgery 2024; 110(10) doi: 10.1097/JS9.0000000000001665
|
| 324 |
Neeraj Patel, Aditi Gupta, Riya Mishra, Soumya V. Menon, Subhashree Ray, Surya Nath Pandey, Kavita Goyal, Haider Ali, Chandana Maji, A. Rekha, Gaurav Gupta, Md Sadique Hussain. Mesothelin in pancreatic cancer: clinical applications and analytical considerations. Clinica Chimica Acta 2026; 579 doi: 10.1016/j.cca.2025.120686
|
| 325 |
Reegan Sturgeon, Paran Goel, Caitlin Molczyk, Ridhi Bhola, Paul M. Grandgenett, Michael A. Hollingsworth, Rakesh K. Singh. Neutrophil Dynamics Contribute to Disease Progression and Poor Survival in Pancreatic Cancer. Cancers 2025; 17(21) doi: 10.3390/cancers17213541
|
| 326 |
Cecilia Bergonzini, Alessandro Gregori, Tessa M. S. Hagens, Vera E. van der Noord, Bob van de Water, Annelien J. M. Zweemer, Bircan Coban, Mjriam Capula, Giulia Mantini, Asia Botto, Francesco Finamore, Ingrid Garajova, Liam A. McDonnell, Thomas Schmidt, Elisa Giovannetti, Erik H. J. Danen. ABCB1 overexpression through locus amplification represents an actionable target to combat paclitaxel resistance in pancreatic cancer cells. Journal of Experimental & Clinical Cancer Research 2024; 43(1) doi: 10.1186/s13046-023-02879-8
|
| 327 |
Yun Bian, Cong Liu, Qi Li, Yinghao Meng, Fang Liu, Hao Zhang, Xu Fang, Jing Li, Jieyu Yu, Xiaochen Feng, Chao Ma, Zengrui Zhao, Li Wang, Jun Xu, Chengwei Shao, Jianping Lu. Preoperative Radiomics Approach to Evaluating Tumor‐Infiltrating CD8+ T Cells in Patients With Pancreatic Ductal Adenocarcinoma Using Noncontrast Magnetic Resonance Imaging. Journal of Magnetic Resonance Imaging 2022; 55(3) doi: 10.1002/jmri.27871
|
| 328 |
Olga Michel, Wojciech Szlasa, Dagmara Baczyńska, Jolanta Saczko, Mounir Tarek, Julita Kulbacka. The role of catechin in electroporation of pancreatic cancer cells – Effects on pore formation and multidrug resistance proteins. Bioelectrochemistry 2022; 147 doi: 10.1016/j.bioelechem.2022.108199
|
| 329 |
Liqiang Liu, Sicheng Xu, Pengbiao Miao, Xing He, Yaorong Peng, Qixian Zhou, Junkai Ren, Zhenyu Zhou, Huilin Ye, Wenbin Li. Extracellular Volume Fraction Combined With Pathological Features of α‐SMA and FAP for Predicting the Prognosis of Patients With Pancreatic Ductal Adenocarcinoma After Surgery and Evaluating the Efficacy of Chemotherapy. Cancer Medicine 2025; 14(19) doi: 10.1002/cam4.71281
|
| 330 |
Penelope Edwards, Byung Woog Kang, Ian Chau. Targeting the Stroma in the Management of Pancreatic Cancer. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.691185
|
| 331 |
Faisal Raza, Lauren Evans, Mahzad Motallebi, Hajra Zafar, Miguel Pereira-Silva, Kalsoom Saleem, Diana Peixoto, Abbas Rahdar, Esmaeel Sharifi, Francisco Veiga, Clare Hoskins, Ana Cláudia Paiva-Santos. Liposome-based diagnostic and therapeutic applications for pancreatic cancer. Acta Biomaterialia 2023; 157 doi: 10.1016/j.actbio.2022.12.013
|
| 332 |
Prachi Bhatt, Jared Hirsch, Paul Cockrum, George Kim, Gabriela Dieguez. The Effects of Adverse Events and Associated Costs on Value-Based Care for Metastatic Pancreatic Ductal Adenocarcinoma. Journal of Health Economics and Outcomes Research 2024; 11(2) doi: 10.36469/001c.124367
|
| 333 |
Gertrud Forika, Eva Kiss, Gabor Petovari, Titanilla Danko, Aron Bertram Gellert, Tibor Krenacs. Modulated Electro-Hyperthermia Supports the Effect of Gemcitabine Both in Sensitive and Resistant Pancreas Adenocarcinoma Cell Lines. Pathology and Oncology Research 2021; 27 doi: 10.3389/pore.2021.1610048
|
| 334 |
Kexin Li, Qingji Huo, Bai-Yan Li, Hiroki Yokota. The Double-Edged Proteins in Cancer Proteomes and the Generation of Induced Tumor-Suppressing Cells (iTSCs). Proteomes 2023; 11(1) doi: 10.3390/proteomes11010005
|
| 335 |
Mohammad Mazharul Islam, Andrea Goertzen, Pankaj K. Singh, Rajib Saha. Exploring the metabolic landscape of pancreatic ductal adenocarcinoma cells using genome-scale metabolic modeling. iScience 2022; 25(6) doi: 10.1016/j.isci.2022.104483
|
| 336 |
Yoo Na Kim, Ketki Patil, Jeonghwa Ma, Griffin A. Dufek, S. Balakrishna Pai. Multifaceted Effects of Kinase Inhibitors on Pancreatic Cancer Cells Reveals Pivotal Entities with Therapeutic Implications. Biomedicines 2023; 11(6) doi: 10.3390/biomedicines11061716
|
| 337 |
Kyle D. G. Saunders, Johanna von Gerichten, Holly-May Lewis, Priyanka Gupta, Matt Spick, Catia Costa, Eirini Velliou, Melanie J. Bailey. Single-Cell Lipidomics Using Analytical Flow LC-MS Characterizes the Response to Chemotherapy in Cultured Pancreatic Cancer Cells. Analytical Chemistry 2023; 95(39) doi: 10.1021/acs.analchem.3c02854
|
| 338 |
Bin Li, Junyi Wang, Jing Liao, Minghui Wu, Xiangshu Yuan, Hezhi Fang, Lijun Shen, Minghua Jiang. YY1 promotes pancreatic cancer cell proliferation by enhancing mitochondrial respiration. Cancer Cell International 2022; 22(1) doi: 10.1186/s12935-022-02712-w
|
| 339 |
Tung-Wei Hsu, Chih-Ming Su, Yen-Hao Su, Po-Hsiang Liao, Charupong Saengboonmee, Wan-Yu Wang, Hsin-An Chen. Adenylosuccinate lyase in pancreatic ductal adenocarcinoma chemoresistance: from purine metabolism to metabolic vulnerability. Cancer Drug Resistance 2026; doi: 10.20517/cdr.2026.58
|
| 340 |
Tzu-Pin Lu, Chien-Hui Wu, Chia-Chen Chang, Han-Ching Chan, Amrita Chattopadhyay, Wen-Chung Lee, Chun-Ju Chiang, Hsin-Ying Lee, Yu-Wen Tien. Distinct Survival Outcomes in Subgroups of Stage III Pancreatic Cancer Patients: Taiwan Cancer Registry and Surveillance, Epidemiology and End Results registry. Annals of Surgical Oncology 2022; 29(3) doi: 10.1245/s10434-021-11030-w
|
| 341 |
Hung Hong Nguyen, Juthamart Maneenet, Tsutomu Fujii, Lorenzo Caggiano, Simon E. Lewis, Suresh Awale. Grandifloridin D: A Potent Antiausterity Agent Targeting Pancreatic Cancer Cells <i>via</i> Akt/mTOR and Autophagy Inhibition. Biological and Pharmaceutical Bulletin 2025; 48(11) doi: 10.1248/bpb.b25-00545
|
| 342 |
Lisa K. Månsson, Anna E. Warsaw, Elizabeth G. Wilbanks, Angela A. Pitenis. Multiscale Mechanics of Granular Biofilms. Tribology Letters 2026; 74(1) doi: 10.1007/s11249-025-02101-0
|
| 343 |
Tahir Basir Khan, Neeraj Choudhary, Sahil Sharma, Dinesh Kumar, Ujjwal Kaushik, Vrinda Gupta, S. Gowri, Md Faiyazuddin, Thomas J. Webster. Reprogramming the pancreatic tumor microenvironment using smart stem cells: A new frontier in cancer therapy. Advances in Cancer Biology - Metastasis 2026; 17 doi: 10.1016/j.adcanc.2026.100188
|
| 344 |
Marcos Roberto de Oliveira. Melittin-induced modulation of mitochondrial physiology: Beyond the antitumoral actions. Toxicon 2025; 266 doi: 10.1016/j.toxicon.2025.108555
|
| 345 |
Monica Sheinin, Susanta Mondal, Kalipada Pahan. Neutralization of p40 Homodimer and p40 Monomer Leads to Tumor Regression in Patient-Derived Xenograft Mice with Pancreatic Cancer. Cancers 2023; 15(24) doi: 10.3390/cancers15245796
|
| 346 |
Diletta Piana, Federica Iavarone, Elisa De Paolis, Gennaro Daniele, Federico Parisella, Angelo Minucci, Viviana Greco, Andrea Urbani. Phenotyping Tumor Heterogeneity through Proteogenomics: Study Models and Challenges. International Journal of Molecular Sciences 2024; 25(16) doi: 10.3390/ijms25168830
|
| 347 |
Hongjing Ai, Rongfang Nie, Xiaosheng Wang. Pathway Enrichment-Based Unsupervised Learning Identifies Novel Subtypes of Cancer-Associated Fibroblasts in Pancreatic Ductal Adenocarcinoma. Interdisciplinary Sciences: Computational Life Sciences 2025; 17(2) doi: 10.1007/s12539-025-00705-7
|
| 348 |
Camilla Pecoraro, Beatrice Faggion, Beatrice Balboni, Daniela Carbone, Godefridus J. Peters, Patrizia Diana, Yehuda G. Assaraf, Elisa Giovannetti. GSK3β as a novel promising target to overcome chemoresistance in pancreatic cancer. Drug Resistance Updates 2021; 58 doi: 10.1016/j.drup.2021.100779
|
| 349 |
Bayan Khasawneh, Abdullah Esmail, Ebtesam Al-Najjar, Seif El Beheary, Maen Abdelrahim. An 81-Year-Old Geriatric Patient with Metastatic Pancreatic Cancer Demonstrating Excellent Response and Well Tolerance to NALIRIFOX: A Case Report and Literature Review. Reports 2025; 8(2) doi: 10.3390/reports8020069
|
| 350 |
Gabriela R. Rossi, Ashley Jensen, Serina Ng, Zhirong Yin, Aimin Li, Anjan Misra, Daniel D. Von Hoff, Lewis Gruber, Misty Gruber, Haiyong Han. Advanced glycation end product (AGE) targeting antibody SIWA318H is efficacious in preclinical models for pancreatic cancer. Scientific Reports 2023; 13(1) doi: 10.1038/s41598-023-44211-6
|
| 351 |
Yiqing Song. Single-Cell RNA-seq Reveals Systemic Immune Remodeling in Pancreatic Ductal Adenocarcinoma. 2026 14th International Conference on Bioinformatics and Computational Biology (ICBCB) 2026; doi: 10.1109/ICBCB69424.2026.11621457
|
| 352 |
Ang Li, Sinan Hou, Jian Chen, Yanfang Jiang. Development and validation of a novel glycolysis-related risk signature for predicting survival in pancreatic adenocarcinoma. Clinica Chimica Acta 2021; 518 doi: 10.1016/j.cca.2021.03.020
|
| 353 |
Kaushal Kundalia, Abdul Hakeem, Michail Papoulas, Mark Mcphail, Shruthi Reddy, Praveen Peddu, Nabil Kibriya, Simon Atkinson, Andreas Prachalias, Parthi Srinivasan, Nigel Heaton, Debashis Sarker, Paul Ross, Yoh Zen, Krishna Menon. Margin ACcentuation for resectable Pancreatic cancer using Irreversible Electroporation – Results from the MACPIE-I study. European Journal of Surgical Oncology 2021; 47(10) doi: 10.1016/j.ejso.2021.05.024
|
| 354 |
Nnenna Elebo, Jones Omoshoro-Jones, Pascaline N. Fru, John Devar, Christiaan De Wet van Zyl, Barend Christiaan Vorster, Martin Smith, Stefano Cacciatore, Luiz F. Zerbini, Geoffrey Candy, Ekene Emmanuel Nweke. Serum Metabolomic and Lipoprotein Profiling of Pancreatic Ductal Adenocarcinoma Patients of African Ancestry. Metabolites 2021; 11(10) doi: 10.3390/metabo11100663
|
| 355 |
Sashikanta Swain, Sudipta Mohakud, Srijani Mandal, Siba Narayan Padhi, Bramhadatta Pattnaik, Sunita Gupta, Sipra Rout, Pravash Ranjan Mishra, Kanhaiyalal Agrawal. Radiomic features of CECT and SUVmax of dual-tracer PET/CT reveal PD-L1 spatial heterogeneity in PDAC. Cancer Imaging 2026; 26(1) doi: 10.1186/s40644-025-00960-3
|
| 356 |
Abdulaziz Alhussan, Nicholas Palmerley, Julian Smazynski, Joanna Karasinska, Daniel J. Renouf, David F. Schaeffer, Wayne Beckham, Abraham S. Alexander, Devika B. Chithrani. Potential of Gold Nanoparticles in Current Radiotherapy Using a Co-Culture Model of Cancer Cells and Cancer Associated Fibroblasts. Cancers 2022; 14(15) doi: 10.3390/cancers14153586
|
| 357 |
Alisa B. Beydogan, Zeynep M. Coskun Yazici, Sema Bolkent. Influences of calorie restriction and lipopolysaccharide therapy on inflammation, cytokine response, and cell proliferation in pancreatic adenocarcinoma mouse model. Journal of Biochemical and Molecular Toxicology 2023; 37(2) doi: 10.1002/jbt.23250
|
| 358 |
Isabell Luisa Wahler, Alexander Damanakis, Nils Große Hokamp, Christiane Bruns, Thomas Schmidt. Therapy of Locally Advanced and Oligometastatic Pancreatic Adenocarcinoma. Cancers 2023; 15(24) doi: 10.3390/cancers15245881
|
| 359 |
Vera Skripova, Ramilia Vlasenkova, Yan Zhou, Igor Astsaturov, Ramziya Kiyamova. Identification of New Regulators of Pancreatic Cancer Cell Sensitivity to Oxaliplatin and Cisplatin. Molecules 2022; 27(4) doi: 10.3390/molecules27041289
|
| 360 |
Bahar Beydogan, Başak Işıldar, Zeynep Mine Coşkun Yazıcı, Meral Koyutürk, Sema Bolkent. Low-dose LPS and calorie restriction combined therapy for pancreatic ductal adenocarcinoma: an in vitro and in vivo study. Marmara Medical Journal 2025; 38(1) doi: 10.5472/marumj.1627620
|
| 361 |
Ashleigh Hull, Yanrui Li, Dylan Bartholomeusz, William Hsieh, William Tieu, Tara L. Pukala, Alexander H. Staudacher, Eva Bezak. Preliminary Development and Testing of C595 Radioimmunoconjugates for Targeting MUC1 Cancer Epitopes in Pancreatic Ductal Adenocarcinoma. Cells 2022; 11(19) doi: 10.3390/cells11192983
|
| 362 |
Catarina Cardoso Araújo, Joana Frias, Francisco Mendes, Miguel Martins, Joana Mota, Maria João Almeida, Tiago Ribeiro, Guilherme Macedo, Miguel Mascarenhas. Unlocking the Potential of AI in EUS and ERCP: A Narrative Review for Pancreaticobiliary Disease. Cancers 2025; 17(7) doi: 10.3390/cancers17071132
|
| 363 |
Fatemeh Sadat Hosseini, Abdolreza Ahmadi, Prashant Kesharwani, Hossein Hosseini, Amirhossein Sahebkar. Regulatory effects of statins on Akt signaling for prevention of cancers. Cellular Signalling 2024; 120 doi: 10.1016/j.cellsig.2024.111213
|
| 364 |
Nachiket Dattatray Garge, Ankita Sharma, Sudeshna Mukherjee, Rajdeep Chowdhury. LncRNAYIYA drives pancreatic cancer proliferation under high‐glucose conditions by reinforcing a RAS–PKM2‐dependent Warburg phenotype. FEBS Letters 2026; 600(13) doi: 10.1002/1873-3468.70378
|
| 365 |
Woosol Chris Hong, Da Eun Lee, Hyeon Woong Kang, Myeong Jin Kim, Minsoo Kim, Ju Hyun Kim, Sungsoon Fang, Hyo Jung Kim, Joon Seong Park. CD74 Promotes a Pro-Inflammatory Tumor Microenvironment by Inducing S100A8 and S100A9 Secretion in Pancreatic Cancer. International Journal of Molecular Sciences 2023; 24(16) doi: 10.3390/ijms241612993
|
| 366 |
Sudhanshu Sharma, Rajesh Singh, Shiva Kant, Manoj K. Mishra. Integrating AI/ML and multi-omics approaches to investigate the role of TNFRSF10A/TRAILR1 and its potential targets in pancreatic cancer. Computers in Biology and Medicine 2025; 193 doi: 10.1016/j.compbiomed.2025.110432
|
| 367 |
Michal Zuzčák, Jan Trnka. Cellular metabolism in pancreatic cancer as a tool for prognosis and treatment (Review). International Journal of Oncology 2022; 61(2) doi: 10.3892/ijo.2022.5383
|
| 368 |
Yonggang Guo, Mohammadamin Morshedi. Cutting-edge nanotechnology: unveiling the role of zinc oxide nanoparticles in combating deadly gastrointestinal tumors. Frontiers in Bioengineering and Biotechnology 2025; 13 doi: 10.3389/fbioe.2025.1547757
|
| 369 |
Thomas J. Vogl, Hamzah Adwan, Leonhard Mann, Ibrahem Al Haj Ibrahem. Accuracy and safety of percutaneous CT-guided pancreatic biopsies. La radiologia medica 2025; 130(12) doi: 10.1007/s11547-025-02087-8
|
| 370 |
Ming Li, Sebastian Freeman, Janusz Franco-Barraza, Kathy Q. Cai, Amy Kim, Sha Jin, Edna Cukierman, Kaiming Ye. A bioprinted sea-and-island multicellular model for dissecting human pancreatic tumor-stroma reciprocity and adaptive metabolism. Biomaterials 2024; 310 doi: 10.1016/j.biomaterials.2024.122631
|
| 371 |
John Martin Velez-Haro, Fernando Pérez-Rodríguez, Sabina Velázquez-Márquez, Humberto Ramírez Medina, Noé Velázquez-Márquez. Pathogens Associated with the Development of Cancer in Humans. 2024; doi: 10.1007/978-3-031-62558-9_16
|
| 372 |
Kestutis Urbonas, Gabija Stachneviciute, Aldona Jasukaitiene, Povilas Ignatavicius, Zilvinas Dambrauskas, Antanas Gulbinas, Giedrius Barauskas, Peng Zhang. Overexpression of EMT-related transcription factors SNAI1 and ZEB1 is associated with more aggressive clinicopathological features of pancreatic cancer. PLOS One 2026; 21(1) doi: 10.1371/journal.pone.0339964
|
| 373 |
Da-Lai Xu, Yuan-Qing He, Bin Xiao, Yuan Si, Jian Shi, Xue-Ang Liu, Lei Tian, Qian Ren, Ya-Song Wu, Yi Zhu. A Novel Sushi-IL15-PD1 CAR-NK92 Cell Line With Enhanced and PD-L1 Targeted Cytotoxicity Against Pancreatic Cancer Cells. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.726985
|
| 374 |
|
| 375 |
Alfred Akinlalu, Komila Rasuleva, Emmanuel Ogberefor, Tommy Gao, Haiyong Han, Pankaj K Singh, Christopher H. Lieu, Christina Coughlan, Todd M. Pitts, Dali Sun. A Fluorescence Resonance Energy Transfer-Based Assay Targeting Tumor-Derived Extracellular Vesicles for Highly Specific Pancreatic Cancer Detection. ACS Nano 2025; 19(50) doi: 10.1021/acsnano.5c10607
|
| 376 |
Emily A. Henderson, Slawomir Lukomski, Brian A. Boone. Emerging applications of cancer bacteriotherapy towards treatment of pancreatic cancer. Frontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1217095
|
| 377 |
Kevin Zhao, Vijayaragavan Muralidharan, Shaun Brown, Anthony Upton, Moammar Alshimirti, Prasad D. Cooray. Neoadjuvant Pembrolizumab Enables Successful Downstaging and Resection of Borderline Resectable MSI-H/dMMR Pancreatic Ductal Adenocarcinoma: A Case Report and Literature Review. Journal of Gastrointestinal Cancer 2025; 56(1) doi: 10.1007/s12029-025-01237-5
|
| 378 |
Oluwateniola Akin-Olugbemi, De’llaijah Lucas, Joy Okoro, Esther Frimpong, Raviteja Bulusu, Romell Stone, Hernan Flores-Rozas, Edward Agyare, Tanise Jackson, Seth Ablordeppey, Sulma Mohammed, Brooke Vintilla, Kelly Herremans, Patrick W. Underwood, Dan Delitto, Grace Thompson, Andrea N. Riner, Jose Trevino, Steven J. Hughes, Song Han, Saunjoo L. Yoon, Christina Gobin, Bodour Salhia, Paul Okunieff, Kristianna M. Fredenburg, John M. Allen, Bereket Machona, R. Renee Reams, Diana J. Wilkie. Building Equitable Cancer Research Infrastructure: Successful Transfer of Patient-Derived Xenograft Technology to a Historically Black University. Cancer Control 2025; 32 doi: 10.1177/10732748251401261
|
| 379 |
Bhavana Hemantha Rao, Pavel Souček, Viktor Hlaváč. Laser Capture Microdissection: A Gear for Pancreatic Cancer Research. International Journal of Molecular Sciences 2022; 23(23) doi: 10.3390/ijms232314566
|
| 380 |
Ioanna A. Anastasiou, Panagiotis Sarantis, Eleni Rebelos, Ioanna Eleftheriadou, Konstantinos N. Tentolouris, Athanasia Katsaouni, Evangelos Koustas, Vasileia Kokala, Michalis V. Karamouzis, Nikolaos Tentolouris. l‐Securinine Induces ROS‐Dependent Apoptosis on Pancreatic Cancer Cells via the PI3K/AKT/mTOR Signaling Pathway. Journal of Biochemical and Molecular Toxicology 2024; 38(11) doi: 10.1002/jbt.70036
|
| 381 |
Jette Bloemberg, Suzanne van Wees, Vera G. Kortman, Aimée Sakes. Design of a wasp-inspired biopsy needle capable of self-propulsion and friction-based tissue transport. Frontiers in Bioengineering and Biotechnology 2025; 12 doi: 10.3389/fbioe.2024.1497221
|
| 382 |
Xiaoxia Cheng, Ting Peng, Tian Chu, Yiqun Yang, Jia Liu, Qinglei Gao, Canhui Cao, Juncheng Wei. Application of single-cell and spatial omics in deciphering cellular hallmarks of cancer drug response and resistance. Journal of Hematology & Oncology 2025; 18(1) doi: 10.1186/s13045-025-01722-1
|
| 383 |
Zhiyu Zhao, Arshdeep Khurana, Frank Antony, John W. Young, Keeley G. Hewton, Zora Brough, Tianshuang Zhong, Seth J. Parker, Franck Duong van Hoa. A Peptidisc-Based Survey of the Plasma Membrane Proteome of a Mammalian Cell. Molecular & Cellular Proteomics 2023; 22(8) doi: 10.1016/j.mcpro.2023.100588
|